Patent Grant
12048791
The disclosed subject matter relates generally to the peritoneal dialysis treatment of end stage renal failure and more specifically to devices, methods, systems, improvements, and components for preparing peritoneal dialysis solution and according to certain embodiments, also performing peritoneal dialysis. As used herein, the term “peritoneal dialysis solution admixer/cycler” refers to a system that generates peritoneal dialysis solution by admixing and, optionally, also performs a peritoneal dialysis treatment. Thus, peritoneal dialysis solution admixer/cyclers generate peritoneal dialysis, but may not perform a peritoneal dialysis treatment.
Peritoneal dialysis is a mature technology that has been in use for many years. It is one of two common forms of dialysis, the other being hemodialysis, which uses an artificial membrane to directly cleanse the blood of a renal patient. Peritoneal dialysis employs the natural membrane of the peritoneum to permit the removal of excess water and toxins from the blood.
In peritoneal dialysis, sterile peritoneal dialysis solution is infused into a patient's peritoneal cavity using a catheter that has been inserted through the abdominal wall. The solution remains in the peritoneal cavity for a dwell period. Osmotic exchange with the patient's blood occurs across the peritoneal membrane, removing urea and other toxins and excess water from the blood. Ions that need to be regulated are also exchanged across the membrane. The removal of excess water results in a higher volume of fluid being removed from the patient than is infused. The net excess is called ultrafiltrate, and the process of removal is called ultrafiltration. After the dwell time, the dialysis solution is removed from the body cavity through the catheter.
Peritoneal dialysis requires the maintenance of strict sterility because of the high risk of peritoneal infection.
In one form of peritoneal dialysis, which is sometimes referred to as cycler-assisted peritoneal dialysis, an automated cycler is used to infuse and drain dialysis solution. This form of peritoneal dialysis treatment can be done automatically at night while the patient sleeps. One of the safety mechanisms for such a peritoneal dialysis treatment is the monitoring by the cycler of the quantity of ultrafiltrate. The cycler performs this monitoring function by measuring the amount of fluid infused and the amount removed to compute the net fluid removal.
The peritoneal dialysis treatment sequence usually begins with an initial drain cycle to empty the peritoneal cavity of spent dialysis solution, except on so-called “dry days” when the patient begins automated peritoneal dialysis treatment without their peritoneal cavity filled with dialysis solution. The cycler then performs a series of fill, dwell, and drain cycles, typically finishing with a fill cycle.
The fill cycle presents a risk of over-pressurizing the peritoneal cavity, which has a low tolerance for excess pressure. In traditional peritoneal dialysis, a dialysis solution container is elevated to certain level above the patient's abdomen so that the fill pressure is determined by the height difference. Automated systems sometimes employ pumps that cannot generate a pressure beyond a certain level, but this system is not foolproof since a fluid column height can arise due to a patient-cycler level difference and cause an overpressure. A reverse height difference can also introduce an error in the fluid balance calculation because of incomplete draining.
Modern cyclers may fill by regulating fill volume during each cycle. The volume may be entered a controller based on a prescription. The prescription, which also determines the composition of the dialysis solution, may be based upon the patient's size, weight, and other criteria. Due to errors, prescriptions may be incorrect or imperfectly implemented resulting in a detriment to patient well-being and health.
Peritoneal dialysis admixing and/or treatment devices, methods, and systems are disclosed. The systems, methods, and devices provide high-level guarantees of sterility and employs relatively inexpensive disposable components to provide pumping. Disclosed systems, methods, and devices and features thereof are adapted for point of use generation of medicament. In particular admixing systems that employ independently-replaceable long term concentrate are disclosed. Features are directed to assurance of sterility and accurate admixing of water and concentrate to generate ready-to-use medicaments and other benefits.
Objects and advantages of embodiments of the disclosed subject matter will become apparent from the following description when considered in conjunction with the accompanying drawings.
Objects and advantages of embodiments of the disclosed subject matter will become apparent from the following description when considered in conjunction with the accompanying drawings.
Embodiments will hereinafter be described in detail below with reference to the accompanying drawings, wherein like reference numerals represent like elements. The accompanying drawings have not necessarily been drawn to scale. Where applicable, some features may not be illustrated to assist in the description of underlying features.
Referring now to
A function provided by the sterilizing filter 115 is to provide safety given that a new sterile disposable component 100B is attached to the concentrate 101 for each peritoneal dialysis treatment. A similar filter may be employed in all the embodiments for the line indicated at 107 conveying the purified water to the peritoneal dialysis solution admixer/cycler 103. Since a new connection is required each time the disposable component 100B is replaced, there is a risk of contamination from the new connection. The sterilizing filter 115 (and others) can be provided as a sterile barrier to protect the sterile interior of the disposable component 100B, thereby ensuring that any contamination resulting from the newly-made connection does not enter the disposable component 100B interior. In addition, the automatic testing of the filter provides assurance that the sterilizing filter 115 integrity has provided the expected sterile fluid. Thus, the testability functions as a guarantee of the filter's sterilizing function. Testing of sterilizing filters using pressurized air testing can be done in various ways, for example, a bubble point test can be performed. Alternatively, a pressure decay test can be done where fluid is pumped across the membrane and the pressure drop measured and compared with a pressure drop representative of an intact filter or pressure is increased on one side, pumping stopped, and the rate of decay of pressure compared to a predefined curve representative of an intact filter. Other means of testing filter integrity may be used, for example, concentrates can include a large-molecule excipient whose presence can be detected using automatic chip-based analyte detection (e.g., attachment of fluid samples to selective fluorophore after flowing through the filter and optical detection after concentration). A feature of the embodiments that use a filter to provide the guarantee, as mentioned, is that the filter forms part of a sterilized unit that is otherwise hermetically sealed or protected by one or more additional sterilizing filters. Thus, in embodiments, the entire sealed and sterilized circuit may have sterilizing filters (1) at all openings to its interior or at least (2) at all openings to which fluid is admitted from the external environment.
Referring now to
Referring now to
In the present and any of the embodiments, the long-term concentrate containers (e.g., monthly disposable) may be replaced on separate schedules so they need not be packaged as a single disposable. This may provide further economy when one concentrate is used at a lower rate by some patients than others, thus allowing the concentrate to be consumed fully before replacing.
It should be evident that there is the potential for the reduction of waste of concentrate by structuring the batch preparation components to permit the changing of concentrates independently of each other and at intervals that cover multiple peritoneal dialysis treatment sessions. Each concentrate container can be used until exhaustion. For embodiments, exhaustion may be defined to be a condition where insufficient concentrate remains in a single container to permit the preparation of a full batch of peritoneal dialysis fluid, a full batch, in embodiments being a quantity of concentrate component sufficient for a single fill cycle. For additional embodiments, Exhaustion may be defined to be a condition where insufficient concentrate remains in a single container to permit the preparation of a full batch of peritoneal dialysis fluid, a number of full batches, in embodiments being a quantity of concentrate component sufficient for full peritoneal dialysis treatment. If two concentrates are mixed to form a batch, each component concentrate may be changed out when the prescription's required contribution of that concentrate to a single batch beyond the remaining volume in the particular container. The residual volume threshold associated with this insufficiency is a fixed volume, so that its percentage of the total volume available from a full container is smaller for a large container than for a smaller container. Thus, in embodiments where the concentrate container is replaced only when the threshold is reached, which container holds large total volume, for example, enough for multiple fill cycles, or better, enough for multiple peritoneal dialysis treatments each including multiple fill cycles, the total waste is much smaller than a disposable component containing concentrate for a single peritoneal dialysis treatment. An example of the latter is discussed below with reference to
In embodiments, the concentrate containers are sized to permit a single peritoneal dialysis treatment. For convenience and convention, a single peritoneal dialysis treatment would be considered a single day's worth of peritoneal dialysis treatment, for example, a series of nocturnal PD cycles ending with a fill. So, a single day's peritoneal dialysis treatment is equal to a sufficient quantity of fluid to perform multiple fill drain cycles. Embodiments in which the concentrate containers are sized for a single day's peritoneal dialysis treatment differ from those described with reference to the embodiments of
Referring now to
Referring to
The double connector 181 supports lines 171 and 128 and provides a pair of connectors 186 and 187 to permit connection of lines 171 and 128 to fill and drain line ports on the peritoneal dialysis solution admixer/cycler 114. The connectors 186 and 187 are sealed by a cap 180. A recess 527 (See
The first concentrate container 105A and concentrate container 105B are both sealed by a frangible seal 154 in each of the lines 164 and 167. The seal is fractured automatically by an actuator after the manifold cartridge 205 is loaded into a receiver that engages it with the interface shown in
Water from the purified water source 104 is received in water line 245 via connection 244 and flows through ultrafilters 237. Pressure of the water suitable for peritoneal dialysis supply is monitored by a pressure sensor 218. A valve 234 selectively controls the flow of water suitable for peritoneal dialysis to a double connector 215. The purified water source terminates at a purified water connector 224 of the double connector 215. The double connector 215 also has a drain terminal connector 225 which splits at a junction 220 into a path that flows to a pair of conductivity sensors 230 and then merges at junction 238 to proceed to a drain 236 and a path that flows directly to the drain 236. The selected path is controlled by valves 232, 240, and 242 which are controlled by a controller 210. The double connector 181 previously described is received in a slot 214 where connections are made to the purified water connector 224 and drain terminal connector 225. A détente mechanism 216 provides tactile and audible feedback to the operator when a home (fully connected) position of the double connector 181 is made by inserting into the receiving slot 214. The receiving slot 214A has a cutting and sealing actuator 212 driven by a controller 210 that cuts the tubes through the window of double connector 181. A connector 239 serves as an adapter to permit connection to various types of drains. The connection platform 219 is also provided with sensors including a moisture sensor 249 located to detect leaking fluid in the connection platform 219, a tilt sensor 226 to indicate the proper orientation of the connection platform 219, and a user interface 228 to interact with the controller 210. The connection platform 219 may be received in a receiving slot 231 and may be formed as a unitary replaceable component. If sterility or leakage problems arise, the connection platform 219 can be replaced easily.
The present embodiment is for a peritoneal dialysis solution admixer/cycler and has a pre-connected fill-drain line 160 with a dialysis solution line 172 attached to an air-line 129. The latter may be formed as a single unit by co-extrusion. In alternative embodiments, the fill-drain line may be separate and connectable with a separate connector. In the present embodiment, the air-line 129 attaches to a pressure-sensing pod 162 located at a distal end of the pre-connected fill-drain line 160. A connector 185 at the distal end of the pre-connected fill-drain line 160 is sealed. Another double line 161 has an air-line 129 and a fluid line 171. The fluid line 171 receives fluid from peritoneal dialysis solution admixer/cycler 114 and the air-line is used for testing the membrane of the filter. The two air-lines 129 connect to respective ports 191 that automatically connect in an actuator portion 140 as described with reference to
The double connector 181 supports lines 171 and 128 and provides a pair of connectors 186 and 187 to permit connection of lines 171 and 128 to fill and drain line ports on the peritoneal dialysis solution admixer/cycler 114. The connectors 186 and 187 are sealed by a cap 180. A recess to engage a détente pin provides tactile confirmation of full engagement of the double connector 181. The double connector 181 has a window 183 that provides access to a cut and seal actuator (not shown in this drawing). When the segments 182 and 184 of lines 171 and 128 are cut, the double connector can remain in place sealing the fill and drain line ports on the peritoneal dialysis solution admixer/cycler 114 until it is removed immediately prior to connecting a fresh double connector 181. This provides a barrier to prevent contaminants from entering the connection platform 219 fluid path, which in turn protects the sterile fluid path used by the peritoneal dialysis solution admixer/cycler 114. The connection platform 219 selects the fluid to be delivered to the fluid line 171. Holes 170 are provided in cartridge support 169 that holds the lines in predefined positions. Holes 170 provide access to pinch actuators that selectively close and open the lines 177. Holes 179 provide access to actuators that fracture the frangible seals 154. Note that the cartridge support 169 is bridged to the manifold 174 by a battery of tubes indicated collectively at 300C. Even though the polymer of the tubes is flexible, however, the cartridge support 169 and the manifold 174 may be readily inserted in a receiving slot.
The double connector 181 supports lines 171 and 128 and provides a pair of connectors 186 and 187 to permit connection of lines 171 and 128 to fill and drain line ports on the peritoneal dialysis solution admixer/cycler 114. The connectors 186 and 187 are sealed by a cap 180. A recess to engage a détente pin provides tactile confirmation of full engagement of the double connector 181. The double connector 181 has a window 183 that provides access to a cut and seal actuator (not shown in this drawing). When the segments 182 and 184 of lines 171 and 128 are cut, the double connector can remain in place sealing the fill and drain line ports on the peritoneal dialysis solution admixer/cycler 114 until it is removed immediately prior to connecting a fresh double connector 181. This provides a barrier to prevent contaminants from entering the connection platform fluid path, which in turn protects the sterile fluid path used by the peritoneal dialysis solution admixer/cycler 114. The connection platform 219 selects the fluid to be delivered to the fluid line 171. Holes 170 are provided in a cartridge support 169 (which may be vacuum-formed) that holds the lines in predefined positions. Holes 170 provide access to pinch actuators that selectively close and open the lines 177. Holes 179 provide access to actuators that fracture the frangible seals 154. Note that the cartridge support 169 is bridged to the manifold 174 by a battery of tubes indicated collectively at 310C. Even though the polymer of the tubes is flexible, however, the cartridge support 169 and the manifold 174 may be readily inserted in a receiving slot. Two concentrates are received through lines 164 and 167, respectively. Each of the lines is filtered by a filter 115 as described with reference to
Note that the actuators and sensors of the embodiments of
As in the
Note that the configuration of
The fluid circuit with pump and valve network 416 is a fluid circuit element with one or more sensors, actuators, and/or pumps which is effective to convey fluid between selected lines 442, 444, 446, 448, 450 and 418 responsively to control signals from the controller 410. Example embodiments are described herein, but many details are known from the prior art for making such a device so they are not elaborated here.
A multiple-container unit 441 includes a pre-filled, pre-sterilized osmotic agent concentrate container 402 for osmotic agent concentrate and another electrolyte concentrate container 404 with electrolyte. The multiple-container unit 441 also contains the mixing container 406 (which is empty) which is large enough to hold a sufficient volume of dialysis solution for the completion of at least one fill cycle of an automated peritoneal dialysis treatment. The containers 402, 404, and 406 may be flexible bag-type containers that collapse when fluid is drawn from them and therefore, do not require any means to vent air into them when drained.
Osmotic agent concentrate container 402, electrolyte concentrate container 404, and mixing container 406 are all connected by respective lines 442, 448, 444, and 446 to the fluid circuit with pump and valve network 416. The fill/drain line (or multiple lines) 450 and a drain line 418 for spent fluid (and other fluids) with a conductivity sensor 428 may also be connected to the fluid circuit with pump and valve network 416. The fluid circuit with pump and valve network 416 also has a fill purified water line 431 for receiving water. The water purifier 420 may be a purifier or any source of sterile and pure water including a pre-sterilized container of water or multiple containers. In a preferred configuration, water purifier 420 may be configured as described in WO2007/118235 (PCT/US2007/066251) and US20150005699, which are hereby incorporated by reference in their entireties. For example, the water purifier 420 may include the flow circuit components of
It should be evident that 416 is an abstraction of the peritoneal dialysis solution admixer/cycler 114 as well as elements of a fluid circuit such as fluid circuit 112 and connection platform 219. It should also be evident that 402 and 404 represent concentrate containers according to any of the disclosed embodiments including the concentrate containers 101, 262 and 264, 105A and 105B. The mixing container 406 corresponds to any of the mixing container embodiments (102) described above. Other elements will be evident from their description with the understanding that the figures represent abstractions thereof for purposes of describing the function. It should also be understood that the number and type of concentrates may differ from the present which is disclosed as an example, only. It should also be evident that the examples of concentrates discussed herein are glucose and electrolyte concentrates but they could be one or other multiples or other concentrates in other embodiments. Also, the osmotic agent concentrate or glucose concentrate is presumed here to include an electrolyte concentrate marker to permit the concentration of osmotic agent to be inferred from a measurement of conductivity of diluted agent with a priori knowledge (stored in a memory used by the controller) of the ratio of osmotic agent concentrate to electrolyte concentrate in the osmotic agent concentrate. See US20150005699. In alternative embodiments, the osmotic agent is not provided with electrolyte and the peritoneal dialysis solution admixer/cycler 400 relies on volumetric proportioning for the transfer of osmotic agent. Note also that the order of concentrate addition may be reversed, with electrolyte being added first.
In an alternative embodiment, part of the water (less than the total used for dilution as discussed below with reference to
Referring now to
The relative amounts of water, osmotic agent concentrate, and electrolyte concentrate may be defined based on the ratiometric proportioning properties of the pump. Since a single pump tube is used to convey all the liquids into the mixing container, most sources of offset from predicted pumping rate (based on shaft rotations, for example) to actual pumping rate affect all the fluids roughly equally.
Referring now to
Referring now to
Although gravimetric and tracer/conductance sensing were described as devices for ensuring proper proportioning and dilution rates for achieving target prescriptions, it should be clear that any embodiments of a peritoneal dialysis solution admixer/cycler disclosed herein may employ ratiometric proportioning as well, particularly where positive displacement pumping is employed. Ratiometric proportioning takes advantage of the volumetric repeatability and predictability of certain pumps. For example, a particular pump can deliver a highly repeatable volume of fluid for a given number of pumping cycles (pump rotations for a peristaltic pump or cycles for a diaphragm pump, for example). If all dialysis solution components (water, osmotic agent concentrate, and electrolyte concentrate, for example) are delivered to the mixing container using the same pump, including, for example, the pumping tube segment of a peristaltic pump, then the volume ratios of the components will, after adjustment for potential flow path and/or viscosity differences as described below, be fully determined by the number of pump cycles used to convey each component.
Rationmetric proportioning may supplement or substitute for measurement of the fluid conductance or density or other measurements. To convert the number of pump cycles to actual displaced mass or volume, a calibration may be performed and/or flow path (including fluid properties) compensation parameters may be employed. The flow path compensation parameters may be respective to each particular fluid flow path and/or fluid type, or may be identical for all fluid paths and fluid types. To provide enhanced accuracy, one or more pump calibration and/or flow path compensation parameters may be generated through a calibration procedure. Typically, flow path compensation factors will be established and stored in non-volatile memory. Typically, one or more flow path calibration procedures will be performed when the peritoneal dialysis solution admixer/cycler is used by a patient. The calibration procedure may be performed after each new fluid set is installed, or before each batch preparation cycle, or even multiple times during the preparation of a single batch. A disposable fluid set may be installed every day. The calibration procedure may be done using water. The calibration may sequentially pump fluid through one or more of the stages provided in Table 1.
In the calibration procedure, fluid is pumped between any or all of the paths identified above. A separate calibration coefficient may be generated for each of the paths. The calibration coefficient may be stored in a memory or non-volatile data store, for example, as a parameter representing the number of ml/per pump rotation (or diaphragm pump cycle), or as a proportionality ratio relative to a particular reference flow path. The actual fluid quantity transported during the calibration step may be measured by any suitable device (flow sensor) including volume or mass measurement devices or direct flow rate measurement with integration, for example, using laser Doppler velocimetry, thermal transit time, magnetohydrodynamics, propeller hydrometer, positive displacement flow measurement, differential pressure through a resistance such as a venturi, nozzle, orifice plate, or other flow obstruction, variable area or rotameter, pitot or impact tube, vortex shedding frequency counting, ultrasonic, or other device. A particularly advantageous device for flow calibration is to measure the transit time of a fluid property perturbation between spaced fluid property sensors as described below with reference to
The pumping system may also be sufficiently repeatable in a way that allows precise ratios to be established without calibration, depending on the predefined tolerances. If the manufacturing tolerances, including materials, are sufficiently controlled, a desired level of control over ratios may be achieved without in situ (point of care) calibration. A particularly sensitive component in terms of guaranteeing repeatability is the pumping tube segment of a peristaltic pump. In a first embodiment, the peristaltic pump tube segment is made from a material whose mechanical and material tolerances are controlled within predefined limits. The lengths of the tubing circuit elements and mechanical parameters are also controlled within respective predefined limits. A calibration may then be done outside the peritoneal dialysis treatment context, e.g., in the laboratory, to calculate precise values to convert pump cycles to fluid quantity transferred for a single lot of replaceable fluid circuits. The calibration may be done for multiple lots. The calibration may also be done for each fluid circuit. The calibration may also be done by the peritoneal dialysis solution admixer/cycler for each fluid circuit. The calibration may also be done for each batch of peritoneal dialysis fluid prepared by the fluid circuit.
Referring to
Double Connectors
Referring now to
Referring to
Referring to
A nozzle 950 may terminate the mixing container inlet 948 tube which extends into the chamber. This causes the extended part of the tube to whip around to inject incoming fluid around the mixing container 952 to agitate the contents and promote effective mixing of the contents. The mixing container sample tube 958 may be terminated by a septum to permit the insertion of a hypodermic needle. The length of the extended part may be at least 3 diameters into the container. The length may be five, 7.5, 10, or 15 diameters. The length may be between 3 diameters and 25 diameters. The length may be at least 5 diameters. Here, the term diameter refers to the tube outer diameter. Note that another alternative is for the inlet line to have a nozzle but no extended part, that is, the nozzle may be located at the wall of the mixing container and be aimed toward the center of the mixing container.
Referring to
Referring to
Referring now to
According to first embodiments, the disclosed subject matter includes a peritoneal dialysis treatment method that includes connecting a fluid circuit to a peritoneal dialysis treatment, such as a peritoneal dialysis treatment, component, in which the fluid circuit includes a mixing container. The peritoneal dialysis treatment, such as a peritoneal dialysis treatment, component has actuators and at least one sensor that engage with the fluid circuit when the peritoneal dialysis treatment, such as a peritoneal dialysis treatment, component receives the fluid circuit such as by connecting the fluid circuit with mounting points, insertion in a slot, or some other alignment mechanism. The method further includes connecting one or more containers of medicament concentrate to the peritoneal dialysis treatment, such as a peritoneal dialysis treatment, component. Each container may have sufficient medicament concentrate to supply multiple peritoneal dialysis treatments. The method further includes flowing purified water and concentrate through the peritoneal dialysis treatment, such as a peritoneal dialysis treatment, component to the fluid circuit to mix a diluted medicament using the concentrate. The flowing operation may include flowing water and concentrate through at least one sterilizing filter. A sterilizing filter, or sterilizing filter, is one which sterilizes the fluid flowing through it by blocking the passage of large particles such as large molecules, bacteria, bacteria fragments, and other substances other than solutes which are used in the medicament. The method further includes treating a patient using diluted medicament concentrate using the peritoneal dialysis treatment, such as a peritoneal dialysis treatment, component. The diluted medicament concentrate is the medicament that is used to treat the patient. The medicament may, in a principal embodiment, be peritoneal dialysis solution. It may be any type of medicament that can be formed at the point of use from concentrate by dilution. The method further includes testing an integrity of the at least one sterilizing filter, replacing the fluid circuit and repeating the connecting a fluid circuit, flowing purified water and concentrate, treating a patient, and testing multiple times without repeating the connecting of one or more containers of medicament concentrate. In other words, the peritoneal dialysis treatment is repeated without replacing the source of concentrate.
In variations thereof, the first embodiments include ones in which, the at least one filter is integrally attached to the fluid circuit. In variations thereof, the first embodiments include ones in which the flowing water and concentrate through at least one sterilizing filter includes flowing water and concentrate through separate filters.
According to second embodiments, the disclosed subject matter includes a fluid circuit for peritoneal dialysis and dialysis solution preparation. A disposable mixing container of polymeric material has a pre-connected fluid circuit, the mixing container and fluid circuit are sealed from an external environment. The fluid circuit includes a fluid flow director that includes a valve network that has junctions and valve portions that mechanically interface with valve actuators to define selectable flow paths in the valve network. The valve network further includes at least two concentrate lines terminated by respective concentrate line connectors, a water line terminated by a water line connector, and a pair of lines connected to the mixing container to permit simultaneous flow into, and flow out from, the mixing container. Each of the concentrate and water lines has an in-line sterilizing filter with an air-line attached to a respective one of the in-line sterilizing filters, the air-line is connected to the respective one such that air forced through the air-line applies pressure to a membrane of the in-line sterilizing filter to permit an integrity test of the filter. If a lack of integrity is determined a corrective action may be taken by the controller. The valve network is embodied in a cartridge with a pumping portion that has a rigid manifold, the manifold being hollow and defining at least some of the junctions and the air-lines connecting to ports fixedly attached to the manifold. The manifold chamber is rigid and defining two separate chambers connected by a pumping tube segment. The air-lines are each collinear with at least a portion of a respective one of the concentrate and water lines. This means they run continuously and parallel together because they are inter-attached along their lengths.
In variations thereof, the second embodiments include ones in which the air-lines are each integral with at least a portion of a respective one of the concentrate and water lines. In still other examples of the second embodiments, the manifold chamber has pressure sensors integrated therein, one at each end of the pumping tube segment. In variations thereof, the second embodiments include ones in which the pumping tube segment is straight. In variations thereof, the second embodiments include ones in which the pressure sensor includes a pressure pod with a diaphragm that serves as a portion of a wall of a respective one of the two separate chambers. In still other examples of the second embodiments, the respective concentrate line connectors are connected by a frame that support portions of the concentrate lines. In still other examples of the second embodiments, the frame has a window and the portions of the concentrate lines pass across the window. In still other examples of the second embodiments, the valve network has a drain line. In still other examples of the second embodiments, the drain and water lines connected by a frame that support portions of the drain and water lines. In still other examples of the second embodiments, the frame has a window and portions of the drain and water lines pass across the window. In still other examples of the second embodiments, the valve portions are supported by a planar element. In still other examples of the second embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions. In still other examples of the second embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions, at least one of the pair of sheets has holes in it to permit valve actuators to contact the valve portions. In still other examples of the second embodiments, the valve portions are tube segments. In still other examples of the second embodiments, the cartridge includes parallel panels with the valve network sandwiched between them, the at least two frangible seals are held in the cartridge aligned with windows in at least one of the panels to permit an actuator to fracture them prior to use thereby allowing the concentrate to flow through the at least two concentrate lines.
According to third embodiments, the disclosed subject matter includes a peritoneal dialysis solution admixer/cycler. The embodiments include at least two concentrate containers with concentrate supply connectors. The concentrate containers have sufficient concentrate to perform multiple peritoneal dialysis treatments, where each peritoneal dialysis treatment includes multiple fill/drain cycles. A daily disposable component includes a disposable mixing container of polymeric material with a pre-connected fluid circuit, the mixing container and fluid circuit are sealed from an external environment. The daily disposable component may be used on a different schedule rather than daily, for example, it may be used to perform peritoneal dialysis treatments once every couple of days or less or more frequently than daily. So, the term “daily disposable component” highlights a range of frequencies of use and embodiments. The fluid circuit includes a fluid flow director that includes a valve network that has junctions and valve portions that mechanically interface with valve actuators to define selectable flow paths in the valve network. The valve network further includes at least two concentrate lines terminated by respective concentrate line connectors, a water line terminated by a water line connector, and a pair of lines connected to the mixing container to permit simultaneous flow into, and flow out from, the mixing container. The concentrate line connectors are connectable to the concentrate supply connectors. Each of the concentrate and water lines has an in-line sterilizing filter with an air-line attached to a respective one of the in-line sterilizing filters, the air-line is connected to the respective one such that air forced through the air-line applies pressure to a membrane of the in-line sterilizing filter to permit an integrity test thereof. The valve network is embodied in, held by, or supported by a cartridge that also has a pumping portion supported by a rigid manifold, the manifold being hollow and defining at least some of the junctions and the air-lines connecting to ports fixedly attached to the manifold. The manifold chamber is rigid and defines two separate chambers connected by a pumping tube segment.
Other examples of the third embodiments include a connection platform that mechanically supports the concentrate line connectors and the concentrate supply connectors to facilitate their interconnection. Other examples of the third embodiments include a connection platform that fluidly couples the concentrate line connectors and the concentrate supply connectors to facilitate their interconnection. In other examples of the third embodiments, the air-lines are each collinear with at least a portion of a respective one of the concentrate and water lines. In other examples of the third embodiments, the air-lines are each integral with at least a portion of a respective one of the concentrate and water lines. In other examples of the third embodiments, the manifold chamber has pressure sensors integrated therein, one at each end of the pumping tube segment. In other examples of the third embodiments, the pumping tube segment is straight. In other examples of the third embodiments, the pressure sensor includes a pressure pod with a diaphragm that serves as a portion of a wall of a respective one of the two separate chambers. In other examples of the third embodiments, the respective concentrate line connectors are connected by a frame that supports portions of the concentrate lines. In other examples of the third embodiments, the frame has a window and the portions of the concentrate lines pass across the window. In other examples of the third embodiments, the valve network has a drain line. In other examples of the third embodiments, the drain and water lines are connected by a frame that supports portions of the drain and water lines. In other examples of the third embodiments, the frame has a window and portions of the drain and water lines pass across the window. In other examples of the third embodiments, the valve portions are supported by a planar element.
In other examples of the third embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions. In other examples of the third embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions, and at least one of the pair of sheets has holes in it to permit valve actuators to contact the valve portions. In other examples of the third embodiments, the valve portions are tube segments. In other examples of the third embodiments, the fluid circuit has a drain line with a drain connector and the connection platform includes a water supply connector and a drain connector to which the water line connector and the drain connector are respectively connectable. In other examples of the third embodiments, the fluid circuit has a drain line with a drain connector and the connection platform includes a water supply connector and a drain connector to which the water line connector and the drain connector are respectively connected. In other examples of the third embodiments, the at least two concentrate containers are contained in a single package. In other examples of the third embodiments, the single package is housed by a single box. In other examples of the third embodiments, the single box is of cardboard. In other examples of the third embodiments, the at least two concentrate containers are cylindrical containers.
According to fourth embodiments, the disclosed subject matter includes a fluid system for dialysis solution preparation. A disposable mixing container is of polymeric material with a pre-connected fluid circuit. The mixing container and fluid circuit are sealed from an external environment. A concentrate container of polymeric material is pre-connected to the fluid circuit. The concentrate container is sealed from an external environment. The fluid circuit includes a valve network that has junctions and valve portions to define selectable flow paths in the valve network. The valve network further includes a concentrate line connected to the concentrate container, a water line terminated by a water line connector, and one or a pair of lines connected to the mixing container to permit intermittent of simultaneous flow into, and flow out from, the mixing container. The water line has an in-line sterilizing filter with an air-line attached thereto, the air-line is connected such that air forced through the air-line applies pressure to a membrane of the in-line sterilizing filter to permit an integrity test thereof. An actuator device has valve actuators, sensors, and a pumping actuator. The fluid circuit has sensor and pumping portions that engage, respectively, along with said valve portions, with the valve actuators, sensors, and a pumping actuator, respectively, of the actuator device.
According to variations thereof, the fourth embodiments are ones in which the valve network is in a cartridge with the pumping portion held by a rigid manifold thereof, the manifold is hollow and defining at least some of said junctions. According to variations thereof, the fourth embodiments are ones in which the air-line connects to a port fixedly attached to said manifold. According to variations thereof, the fourth embodiments are ones in which the manifold is rigid and has two separate chambers connected by the pumping portion. According to variations thereof, the fourth embodiments are ones in which the valve network is supported by a panel providing support for the cartridge, the manifold is connected to the panel. According to variations thereof, the fourth embodiments are ones in which the valve network is supported by a panel, the manifold is spaced apart from the panel. According to variations thereof, the fourth embodiments are ones in which each of said two separate chambers has a pressure sensor integrated therein, one at each end of said pumping portion. According to variations thereof, the fourth embodiments are ones in which each pressure sensor includes a pressure pod with a diaphragm that serves as a portion of a wall of a respective one of the two separate chambers. According to variations thereof, the fourth embodiments are ones in which respective concentrate line connectors are connected by a frame that supports a portion of the concentrate line. According to variations thereof, the fourth embodiments are ones in which the frame has a window and the portion of the concentrate line passes across the window. According to variations thereof, the fourth embodiments are ones in which the valve network has a drain line. According to variations thereof, the fourth embodiments are ones in which the valve network has a fill/drain line connectable to a peritoneal catheter. According to variations thereof, the fourth embodiments are ones in which the valve network has a fill/drain line connectable to a peritoneal catheter. According to variations thereof, the fourth embodiments are ones in which the fill/drain line is pre-connected to the valve network and sealed by a removable end cap.
According to variations thereof, the fourth embodiments are ones in which the drain and water lines are connected by a frame that supports portions of the drain and water lines. According to variations thereof, the fourth embodiments are ones in which the frame has a window and a portion of the concentrate line crosses the window. According to variations thereof, the fourth embodiments are ones in which the valve portions are supported by a planar element. According to variations thereof, the fourth embodiments are ones in which the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions. According to variations thereof, the fourth embodiments are ones in which the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions, at least one of the pair of sheets has holes in it to permit valve actuators to contact the valve portions. According to variations thereof, the fourth embodiments are ones in which the valve portions are tube segments. According to variations thereof, the fourth embodiments are ones in which the valve portions are tube segments. According to variations thereof, the fourth embodiments are ones in which the concentrate line is sealed by a frangible seal. According to variations thereof, the fourth embodiments are ones in which the panel is one of two parallel panels with said valve network sandwiched between them, the valve portion held in alignment with a window in at least one of the two parallel panels to permit an actuator to access the valve portion. According to variations thereof, the fourth embodiments are ones in which the two parallel panels are portions of a single folded panel. According to variations thereof, the fourth embodiments are ones in which the valve network includes the concentrate line which is sealed by a frangible seal thereby separating the concentrate from a remainder of the fluid circuit until the frangible seal is fractured.
According to variations thereof, the fourth embodiments are ones that include a second sterilizing filter connected in series with said in-line sterilizing filter by a flow channel to prevent grow-through contamination between membranes thereof. According to variations thereof, the fourth embodiments are ones in which the mixing container and concentrate container are defined by two bonded flexible panels along seams to define the mixing container and concentrate container. According to variations thereof, the fourth embodiments are ones in which the seams are integral as formed by welding or adhesive bonding. According to variations thereof, the fourth embodiments are ones in which the fluid circuit encloses a sterile internal volume. According to variations thereof, the fourth embodiments are ones in which the actuator device includes a peritoneal dialysis cycler. According to variations thereof, the fourth embodiments are ones in which the actuator device includes a peritoneal dialysis cycler. According to variations thereof, the fourth embodiments are ones in which the actuator device has a cut-and-seal device and a receiving slot that receives said frame and aligns the window with the cut-and-seal device. According to variations thereof, the fourth embodiments are ones in which the actuator device has a controller programmed to activate the cut-and-seal device to cut and seal said concentrate line thereby permitting the fluid circuit to be separated from the frame and a stub portion of the concentrate line. According to variations thereof, the fourth embodiments are ones in which the frame and a stub portion of the concentrate line collectively remain in place on the actuator device when separated from the fluid circuit. According to variations thereof, the fourth embodiments are ones in which the frame and stub portion act as a seal on connectors of the actuator device.
According to fifth embodiments, the disclosed subject matter includes a system for the preparation of sterile peritoneal dialysis fluid that includes a disposable fluid circuit with a pumping tube segment and multiple valve segments, and a peritoneal dialysis solution admixer/cycler dialysis treatment device with at least one pumping actuator positioned to engage the at least one pumping tube segment and multiple valve actuators positioned to engage the valve segments. A first of the multiple valve segments is connected to a fluid inlet. The disposable fluid circuit has a sterilizing filter connected between a fluid inlet connector and the first of the multiple valve segments. A first concentrate container has sufficient concentrate for the preparation of enough peritoneal dialysis solution to perform multiple peritoneal dialysis treatments, wherein each peritoneal dialysis treatment includes multiple fill/drain cycles. The disposable fluid circuit has an integrally-attached mixing container sized to hold sufficient peritoneal dialysis solution for at least a single fill/drain cycle. An interconnection module has a primary concentrate connector and a primary water connector, to which the first concentrate container is connected once every multiple peritoneal dialysis treatments, the interconnection module also has a common secondary connector to which the disposable fluid circuit fluid inlet connector is connected once every peritoneal dialysis treatment. The interconnection module has a valve network controlled by the programmable controller that selects water or concentrate to be drawn by the peritoneal dialysis solution admixer/cycler dialysis treatment device through the common secondary connector. The peritoneal dialysis solution admixer/cycler dialysis treatment device has a programmable controller programmed to control the pumping actuator to pump concentrate and water into the mixing container to make a batch of peritoneal dialysis fluid and subsequently to perform a fill/drain cycle, which includes draining spent peritoneal dialysis solution and pumping a fill of the peritoneal dialysis solution from the mixing container.
In other examples of the fifth embodiments, the disposable fluid circuit has a second concentrate inlet with a sterilizing filter connected between the second concentrate inlet and a third of the multiple valve segments. Other examples of the fifth embodiments include a second concentrate container that includes concentrate for the preparation of enough peritoneal dialysis solution to perform multiple peritoneal dialysis treatments, wherein each peritoneal dialysis treatment includes multiple fill/drain cycles, wherein the first and second concentrate inlets are connected to the first and second concentrate containers by a double connector that carries the first concentrate inlet connector and a second concentrate inlet connector of the disposable fluid circuit, the double connector making connections for the first concentrate inlet connector and the second concentrate inlet simultaneously to the first and second concentrate containers. Other examples of the fifth embodiments include a controller, the controller is programmed to calculate and store data representing a volume of water or concentrate remaining in a portion of the valve network after selecting water or concentrate to be drawn by the peritoneal dialysis solution admixer/cycler dialysis treatment device and to control the pump responsively to the data representing a volume of water or concentrate.
According to sixth embodiments, the disclosed subject matter includes a method of performing a peritoneal dialysis treatment. The method includes drawing a concentrate and water through a sterilizing filter in predefined quantities to make a sufficient quantity of peritoneal dialysis solution for a peritoneal dialysis treatment of multiple fill/drain cycles. The drawing includes, using an interconnection module, connecting water and concentrate in succession to a common inlet of a disposable fluid circuit to which the sterilizing filter is integrally attached. The method further includes testing the sterilizing filter by means of an air pressure test and using, or preventing use of, the quantity for a peritoneal dialysis fill and drain cycle depending on a result of the testing.
Other examples of the sixth embodiments include connecting a long-term concentrate container to the interconnection module once every multiple peritoneal dialysis treatments. Other examples of the sixth embodiments include connecting a peritoneal dialysis treatment circuit that has the sterilizing filter integrally attached thereto, to the interconnection module once every single peritoneal dialysis treatment. Other examples of the sixth embodiments include mixing the water and the concentrate.
In other examples of the sixth embodiments, the drawing and the mixing are performed using a single common pump.
According to seventh embodiments, the disclosed subject matter includes a method of performing a peritoneal dialysis treatment. The method includes drawing a concentrate and water through respective sterilizing filters in predefined quantities to make a sufficient quantity of peritoneal dialysis solution for a single fill of a peritoneal dialysis treatment. The drawing includes, using an interconnection module, flowing water and concentrate in succession to a mixing container by switching flow paths in a peritoneal dialysis cycler. The method further includes testing the sterilizing filter by means of an air pressure test and using, or preventing use of, the quantity for a peritoneal dialysis fill and drain cycle depending on a result of the testing.
Other examples of the seventh embodiments include connecting a long-term concentrate container to the interconnection module once every multiple peritoneal dialysis treatments. Other examples of the seventh embodiments include connecting a peritoneal dialysis treatment circuit that has the respective sterilizing filters integrally attached thereto, to the interconnection module once every single peritoneal dialysis treatment. Other examples of the seventh embodiments include mixing the water and the concentrate. In other examples of the seventh embodiments, the drawing and the mixing are performed using a single common pump. Other examples of the seventh embodiments include the connecting a peritoneal dialysis treatment circuit and removing at least one sterile seal from water and concentrate connectors and connecting one or more new connectors of the peritoneal dialysis treatment circuit to water and concentrate connectors and wherein following the using the quantity, cutting one or more portions of the one or more new connectors to create at least one new sterile seal. In other examples of the seventh embodiments, the interconnection module supports a connector of the concentrate container, the connecting of a long-term concentrate connector which includes replacing the connector of the concentrate container, and the connecting a peritoneal dialysis treatment circuit includes connecting the peritoneal dialysis treatment circuit to the connector of the concentrate container. In other examples of the seventh embodiments, the connecting water and concentrate in succession using the interconnection module includes washing a fixed volume of concentrate from a common outlet of the interconnection module and the disposable fluid circuit inlet, the method further comprising, using a controller used to make the sufficient quantity, calculating an amount of the fixed volume and controlling an amount of water pumped to form the sufficient quantity responsively to a result of the calculating.
According to eighth embodiments, the disclosed subject matter includes a method of making a fluid circuit that has a chamber prefilled with medicament concentrate. The method includes integrally connecting a fluid circuit with a chamber and connecting a sterilizing filter with the chamber. The method is performed in such a way that the integrally connecting and connecting a sterilizing filter form an assembly with a sealed volume that is separated from the outside environment by walls thereof, a frangible plug in a concentrate outlet line stemming from the chamber, and a membrane of the sterilizing filter. The method includes sterilizing the assembly and sterile-filling the chamber with concentrate through the sterilizing filter. The method further includes heat welding and cutting a line connecting the sterilizing filter and the chamber and finally subjecting the fluid circuit and chamber to gamma or e-beam sterilization to terminally sterilize the same. In the embodiments, the sterilizing filter is not one integrated in the product—e.g. pre-connected to multiple daily disposable components. Also, instead of cutting and heat welding, lines may be sealed by crimping a permanent clip or other means.
According to ninth embodiments, the disclosed subject matter includes a fluid circuit for peritoneal dialysis and dialysis solution preparation. The circuit includes a disposable mixing container of polymeric material with a pre-connected fluid circuit, the mixing container and fluid circuit being sealed from an external environment. A concentrate container is of polymeric material and is pre-connected to the fluid circuit and sealed from an external environment. The fluid circuit includes a fluid flow director that includes a valve network that has junctions and valve portions that mechanically interface with valve actuators to define selectable flow paths in the valve network. The valve network further includes a concentrate line connected to the concentrate container, a water line terminated by a water line connector, and a pair of lines connected to the mixing container to permit simultaneous flow into, and flow out from, the mixing container. The water line has an in-line sterilizing filter with an air-line attached thereto, the air-line is connected such that air forced through the air-line applies pressure to a membrane of the in-line sterilizing filter to permit an integrity test thereof. The valve network is embodied in a cartridge with a pumping portion that has a rigid manifold, the manifold being hollow and defining at least some of the junctions, and the air-line connects to a port fixedly attached to the manifold. The manifold is rigid and includes two separate chambers connected by a pumping tube segment.
In other examples of the ninth embodiments, the air-line is collinear with at least a portion of a respective one of the concentrate and water lines. In other examples of the ninth embodiments, the valve network is supported by a panel, and the manifold is connected to the panel. In other examples of the ninth embodiments, the valve network is supported by a panel, and the manifold is spaced apart from the panel. In other examples of the ninth embodiments, the air-line is integral with at least a portion of a respective one of the concentrate and water lines. In other examples of the ninth embodiments, the manifold chamber has pressure sensors integrated therein, one at each end of the pumping tube segment. In other examples of the ninth embodiments, the pumping tube segment is straight. In other examples of the ninth embodiments, pressure sensor includes a pressure pod with a diaphragm that serves as a portion of a wall of a respective one of the two separate chambers. In other examples of the ninth embodiments, respective concentrate line connectors are connected by a frame that supports a portion of the concentrate line. In other examples of the ninth embodiments, the frame has a window and a portion of the concentrate line passes across the window. In other examples of the ninth embodiments, the valve network has a drain line. In other examples of the ninth embodiments, the valve network has a fill/drain line connectable to a peritoneal catheter. In other examples of the ninth embodiments, the fill/drain line is sealed by a removable end cap.
In other examples of the ninth embodiments, the fill/drain line has a second air-line collinear with the fill/drain line, connected at an end of the fill/drain line to a pressure pod connected to the fill/drain line to measure a pressure therewithin. In other examples of the ninth embodiments, the drain and water lines are connected by a frame that supports portions of the drain and water lines. In other examples of the ninth embodiments, the frame has a window and portions of the drain and water lines pass across the window. In other examples of the ninth embodiments, the valve portions are supported by a planar element. In other examples of the ninth embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions. In other examples of the ninth embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions, at least one of the pair of sheets having holes to permit valve actuators to contact the valve portions. In other examples of the ninth embodiments, the valve portions are tube segments. In other examples of the ninth embodiments, the concentrate line is sealed by a frangible seal. In other examples of the ninth embodiments, the cartridge includes parallel panels with the valve network sandwiched between them, and the frangible seal is held in the cartridge aligned with windows in at least one of the panels to permit an actuator to fracture them prior to use thereby allowing the concentrate to flow through the concentrate line. In other examples of the ninth embodiments, the cartridge includes a single folded panel forming parallel panel portions with the valve network sandwiched between them, and the frangible seal is held in the cartridge aligned with windows in at least one of the panels to permit an actuator to fracture them prior to use thereby allowing the concentrate to flow through the concentrate line. In other examples of the ninth embodiments, the valve network includes the concentrate line which is sealed by a frangible seal thereby separating the concentrate from the rest of the fluid circuit until the frangible seal is fractured.
Other examples of the ninth embodiments include a second sterilizing filter connected in series with the in-line sterilizing filter such that the second and in-line sterilizing filters are separated by a flow channel to prevent grow-through contamination between membranes thereof. In other examples of the ninth embodiments, the mixing container and concentrate container are defined by two bonded flexible panels along seams to define the mixing container and concentrate container. In other examples of the ninth embodiments, the seams are a result of thermal welding. In other examples of the ninth embodiments, the fluid circuit encloses a sterile internal volume.
According to tenth embodiments, the disclosed subject matter includes a fluid line connector with at least one thermoplastic tube supported in a frame such that the at least one thermoplastic tube is accessible from opposite sides of the frame. The frame has an overhanging ridge at one end and at least one connector that is fluidly coupled at an opposite end to the at least one thermoplastic tube. A cap is fitted to the frame to cover the at least one connector. The at least one tube extends through holes in the frame at an end thereof adjacent to the overhanging ridge. In other examples of the tenth embodiments, the frame has a recess shaped to engage a détente pin along an elongated side thereof. In other examples of the tenth embodiments, the frame has an oval-shaped recess, and the at least one connector is located within the oval-shaped recess. In other examples of the tenth embodiments, the cap fits in the oval-shaped recess to define a tortuous path between the at least one connector and an access of the oval-shaped recess. In other examples of the tenth embodiments, at least one connector and the at least one thermoplastic tubes are at least two.
According to eleventh embodiments, the disclosed subject matter includes a connector system with a connector component that has at least one thermoplastic tube supported in a frame such that the at least one thermoplastic tube is accessible from opposite sides of the frame. The frame has an overhanging ridge at one end and at least one connector that is fluidly coupled at an opposite end to the at least one thermoplastic tube. A cap is fitted to the frame to cover the at least one connector. The at least one tube extends through holes in the frame at an end thereof adjacent to the overhanging ridge. A fluid supply device with at least one supply connector that mates with the at least one connector has a portion shaped to engage the frame to align the at least one thermoplastic tube with a tube cut-and-seal device.
In other examples of the eleventh embodiments, the cut-and-seal device cuts the at least one thermoplastic tube and seals it at both cut ends, the connector component is configured to permit the at least one thermoplastic tube to be withdrawn from the one end leaving the frame and at least one connector in place on the at least one supply connector to cover and protect it from contamination until it is replaced by another connector component. In other examples of the eleventh embodiments, the frame has a recess shaped to engage a détente pin along an elongated side thereof. In other examples of the eleventh embodiments, the frame has an oval-shaped recess, and the at least one connector is located within the oval-shaped recess. In other examples of the eleventh embodiments, the cap fits in the oval-shaped recess to define a tortuous path between the at least one connector and an access of the oval-shaped recess. In other examples of the eleventh embodiments, the at least one connector and the at least one thermoplastic tubes are at least two.
According to twelfth embodiments, the disclosed subject matter includes a fluid system for peritoneal dialysis and dialysis solution preparation. A disposable mixing container of polymeric material has a pre-connected fluid circuit. The mixing container and fluid circuit are sealed from an external environment. A concentrate container is of polymeric material pre-connected to the fluid circuit. The concentrate container is sealed from an external environment. The fluid circuit includes a fluid flow director that includes a valve network that has junctions and valve portions that mechanically engage valve actuators to define selectable flow paths in the valve network. The valve network further includes a concentrate line connected to the concentrate container, a water line terminated by a water line connector, and a pair of lines connected to the mixing container to permit simultaneous flow into, and flow out from, the mixing container. The water line has an in-line sterilizing filter with an air-line attached thereto, the air-line is connected such that air forced through the air-line applies pressure to a membrane of the in-line sterilizing filter to permit an integrity test thereof. An actuator device has valve actuators, sensors, and a pumping actuator. The fluid circuit has sensor and pumping portions that engage, respectively, along with the valve portions, with effecters of the actuator device.
In other examples of the twelfth embodiments, the valve network is in a cartridge with the pumping portion held by a rigid manifold thereof, the manifold is hollow, and defines at least some of the junctions. In other examples of the twelfth embodiments, the air-line connects to a port fixedly attached to the manifold. In other examples of the twelfth embodiments, the manifold is rigid and has two separate chambers connected by the pumping portion. In other examples of the twelfth embodiments, the valve network is supported by a panel providing support for the cartridge, and the manifold is connected to the panel. In other examples of the twelfth embodiments, the valve network is supported by a panel, and the manifold is spaced apart from the panel. In other examples of the twelfth embodiments, the manifold chamber has pressure sensors integrated therein, one at each end of the pumping portion. In other examples of the twelfth embodiments, the pressure sensor includes a pressure pod with a diaphragm that serves as a portion of a wall of a respective one of the two separate chambers. In other examples of the twelfth embodiments, the respective concentrate line connectors are connected by a frame that supports a portion of the concentrate line. In other examples of the twelfth embodiments, the frame has a window and a portion of the concentrate line passes across the window. In other examples of the twelfth embodiments, the valve network has a drain line. In other examples of the twelfth embodiments, the valve network has a fill/drain line connectable to a peritoneal catheter. In other examples of the twelfth embodiments, the fill/drain line is sealed by a removable end cap. In other examples of the twelfth embodiments, the fill/drain line has a second air-line collinear with the fill/drain line, connected at an end of the fill/drain line to a pressure pod connected to the fill/drain line to measure a pressure therewithin. In other examples of the twelfth embodiments, the drain and water lines are connected by a frame that supports portions of the drain and water lines.
In other examples of the twelfth embodiments, the frame has a window and portions of the drain and water lines pass across the window. In other examples of the twelfth embodiments, the valve portions are supported by a planar element. In other examples of the twelfth embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions. In other examples of the twelfth embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions, and at least one of the pair of sheets has holes in it to permit valve actuators to contact the valve portions. In other examples of the twelfth embodiments, the valve portions are tube segments. In other examples of the twelfth embodiments, the valve portions are tube segments. In other examples of the twelfth embodiments, the concentrate line is sealed by a frangible seal. In other examples of the twelfth embodiments, the cartridge includes parallel panels with the valve network sandwiched between them, and the frangible seal is held in the cartridge and aligned with windows in at least one of the panels to permit an actuator to fracture them prior to use, thereby allowing the concentrate to flow through the concentrate line. In other examples of the twelfth embodiments, the cartridge includes a single folded panel forming parallel panel portions with the valve network sandwiched between them, and the frangible seal is held in the cartridge and aligned with windows in at least one of the panels to permit an actuator to fracture them prior to use, thereby allowing the concentrate to flow through the concentrate line. In other examples of the twelfth embodiments, the valve network includes the concentrate line which is sealed by a frangible seal thereby separating the concentrate from the rest of the fluid circuit until the frangible seal is fractured. Other examples of the twelfth embodiments include a second sterilizing filter connected in series with the in-line sterilizing filter such that the second and in-line sterilizing filters are separated by a flow channel to prevent grow-through contamination between membranes thereof. In other examples of the twelfth embodiments, the mixing container and concentrate container are defined by two bonded flexible panels along seams to define the mixing container and concentrate container. In other examples of the twelfth embodiments, the seams are a result of thermal welding. In other examples of the twelfth embodiments, the fluid circuit encloses a sterile internal volume. In other examples of the twelfth embodiments, the actuator device includes a peritoneal dialysis cycler. In other examples of the twelfth embodiments, the actuator device has a cut-and-seal device and a receiving slot that receives the frame and aligns the window with the cut-and-seal device. In other examples of the twelfth embodiments, the actuator device has a controller programmed to activate the cut-and-seal device to cut and seal the concentrate line thereby permitting the fluid circuit to be separated from the frame and the concentrate line connector, as well as from a stub portion of the concentrate line, which collectively remain in place on the actuator device to act as a seal on connectors of the actuator device.
According to thirteenth embodiments, the disclosed subject matter includes a peritoneal dialysis treatment method. The method includes connecting a fluid circuit to a fluid admixer, the fluid circuit includes a mixing container. The admixer has actuators and that engage with the fluid circuit when received thereby. The method further includes connecting one or more containers of medicament concentrate to the fluid circuit, each container has sufficient medicament concentrate for multiple peritoneal dialysis treatments and using the admixer, flowing purified water and concentrate through the fluid circuit to the mixing container to prepare a medicament in the mixing container by admixing and diluting the medicament concentrate. The flowing includes flowing water and concentrate through at least one sterilizing filter to ensure sterility of the water and concentrate. ensuring an integrity of at least one sterilizing filter by testing the at least one sterilizing filter or providing serially-connected redundant sterilizing filters. The method further includes treating a patient using the prepared medicament in the mixing container. replacing the fluid circuit with a new fluid circuit and repeating the connecting a fluid circuit, flowing purified water and concentrate, treating a patient, without replacing said one or more containers of medicament concentrate.
In other examples of the thirteenth embodiments, the at least one filter is integrally attached to the fluid circuit. In other examples of the thirteenth embodiments, the flowing water and concentrate through at least one sterilizing filter includes flowing water and concentrate through separate filters.
According to fourteenth embodiments, the disclosed subject matter includes a fluid circuit for peritoneal dialysis and dialysis solution preparation. A disposable mixing container of polymeric material has a pre-connected fluid circuit. The mixing container and fluid circuit are sealed from an external environment. A concentrate container of polymeric material is pre-connected to the fluid circuit. The concentrate container is sealed from an external environment. The fluid circuit includes a fluid flow director that includes a valve network that has junctions and valve portions that mechanically engage valve actuators to define selectable flow paths in the valve network. The valve network further includes a concentrate line connected to the concentrate container, a water line terminated by a water line connector, and a pair of lines connected to the mixing container to permit simultaneous flow into, and flow out from, the mixing container. A fluid line has an in-line sterilizing filter. The valve network is positioned and held in a cartridge that has a pumping portion supported by a rigid manifold. The manifold is hollow and defines at least some of the junctions. The manifold is rigid and defining two separate chambers connected by a pumping tube segment.
In other examples of the fourteenth embodiments, the in-line sterilizing filter has an air-line attached thereto; the air-line is connected such that air forced through the air-line applies pressure to a membrane of the in-line sterilizing filter to permit an integrity test thereof, said air-line also connecting to a port fixedly attached to the manifold. In other examples of the fourteenth embodiments, the air-line is collinear with at least a portion of a respective one of the concentrate and water lines. In other examples of the fourteenth embodiments, the valve network is supported by a panel and the manifold is connected to the panel. In other examples of the fourteenth embodiments, the valve network is supported by a panel and the manifold is spaced apart from the panel. In other examples of the fourteenth embodiments, the air-line is integral with at least a portion of a respective one of the concentrate and water lines.
In other examples of the fourteenth embodiments, the manifold chamber has pressure sensors integrated therein, one at each end of the pumping tube segment. In other examples of the fourteenth embodiments, the pumping tube segment is straight. In other examples of the fourteenth embodiments, the pressure sensor includes a pressure pod with a diaphragm that serves as a portion of a wall of a respective one of the two separate chambers. In other examples of the fourteenth embodiments, the respective concentrate line connectors are connected by a frame that supports a portion of the concentrate line. In other examples of the fourteenth embodiments, the frame has a window and the portion of the concentrate line passes across the window. In other examples of the fourteenth embodiments, the valve network has a drain line. In other examples of the fourteenth embodiments, the valve network has a fill/drain line connectable to a peritoneal catheter. In other examples of the fourteenth embodiments, the fill/drain line is sealed by a removable end cap. In other examples of the fourteenth embodiments, the fill/drain line has a second air-line collinear with the fill/drain line, connected at an end of the fill/drain line to a pressure pod connected to the fill/drain line to measure a pressure therewithin. In other examples of the fourteenth embodiments, the drain and water lines are connected by a frame that supports portions of the drain and water lines. In other examples of the fourteenth embodiments, the frame has a window and portions of the drain and water lines pass across the window. In other examples of the fourteenth embodiments, the valve portions are supported by a planar element. In other examples of the fourteenth embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions. In other examples of the fourteenth embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions, and at least one of the pair of sheets has holes in it to permit valve actuators to contact the valve portions. In other examples of the fourteenth embodiments, the valve portions are tube segments. In other examples of the fourteenth embodiments, the concentrate line has a valve portion exposed for access by a valve actuator. In other examples of the fourteenth embodiments, the cartridge includes parallel panels with the valve network sandwiched between them, and the valve portion held in the cartridge is aligned with a window in at least one of the panels to permit an actuator to access the valve portion. In other examples of the fourteenth embodiments, the cartridge includes a single folded panel forming parallel panel portions with the valve network sandwiched between them, and the valve portion held in the cartridge is aligned with a windows in at least one of the panels to permit an actuator to access the valve portion. Other examples of the fourteenth embodiments include a second sterilizing filter connected in series with the in-line sterilizing filter such that the second and in-line sterilizing filters are separated by a flow channel to prevent grow-through contamination between membranes thereof. In other examples of the fourteenth embodiments, the mixing container and concentrate container are defined by two bonded flexible panels along seams that define the mixing container and concentrate container. In other examples of the fourteenth embodiments, the seams are a result of thermal welding. In other examples of the fourteenth embodiments, the fluid circuit encloses a sterile internal volume.
According to fifteenth embodiments, the disclosed subject matter includes a system for performing a peritoneal dialysis treatment. At least two concentrate containers have concentrate supply connectors. The concentrate containers have sufficient concentrate to perform multiple peritoneal dialysis treatments, where each peritoneal dialysis treatment includes multiple fill/drain cycles. A daily disposable component includes a disposable mixing container of polymeric material with a pre-connected fluid circuit. The mixing container and fluid circuit are sealed from an external environment. The fluid circuit includes a fluid flow director that includes a valve network that has junctions and valve portions that mechanically engage valve actuators to define selectable flow paths in the valve network. The valve network further includes a fluid inlet line and a pair of lines connected to the mixing container to permit simultaneous flow into, and flow out from, the mixing container. The fluid inlet line has an in-line sterilizing filter with an air-line attached to the in-line sterilizing filter. The air-line is connected such that air forced through the air-line applies pressure to a membrane of the in-line sterilizing filter to permit an integrity test thereof. The valve network is positioned and held in a cartridge that has a pumping portion supported by a rigid manifold, a manifold that is hollow and defines at least some of the junctions, and air-lines connecting to ports fixedly attached to the manifold. The manifold chamber is rigid and defines two separate chambers connected by a pumping tube segment.
Other examples of the fifteenth embodiments include a connection platform that mechanically supports the at least two concentrate containers and selectively couples them to the fluid inlet line.
Other examples of the fifteenth embodiments include a connection platform with a water source and attachments for the at least two concentrate containers, the connection platform having a valve network that fluidly couples the concentrate containers and the water source to the fluid inlet line.
In other examples of the fifteenth embodiments, an air-line is collinear with at least a portion of the fluid inlet line. In other examples of the fifteenth embodiments, an air-line is attached along at least a portion of the fluid inlet line. In other examples of the fifteenth embodiments, the manifold chamber has pressure sensors integrated therein, one at each end of the pumping tube segment. In other examples of the fifteenth embodiments, the pumping tube segment is straight. In other examples of the fifteenth embodiments, the pressure sensor includes a pressure pod with a diaphragm that serves as a portion of a wall of a respective one of the two separate chambers. In other examples of the fifteenth embodiments, the respective concentrate line connectors are connected by a frame that supports portions of the concentrate lines. In other examples of the fifteenth embodiments, the frame has a window and portions of the concentrate lines pass across the window. In other examples of the fifteenth embodiments, the valve network has a drain line. In other examples of the fifteenth embodiments, the drain and fluid lines are connected by a frame that supports portions of the drain and fluid lines. In other examples of the fifteenth embodiments, the frame has a window and portions of the drain and fluid lines pass across the window. In other examples of the fifteenth embodiments, the valve portions are supported by a planar element. In other examples of the fifteenth embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions. In other examples of the fifteenth embodiments, the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions, and at least one of the pair of sheets has holes in it to permit valve actuators to contact the valve portions. In other examples of the fifteenth embodiments, the valve portions are tube segments. In other examples of the fifteenth embodiments, the fluid circuit has a drain line with a drain connector, the fluid line has a fluid line connector, and the connection platform includes a fluid supply connector and a drain receiving connector to which the fluid line connector and the drain connector are respectively connectable. In other examples of the fifteenth embodiments, the at least two concentrate containers are contained in a single package. In other examples of the fifteenth embodiments, the single package is housed by a single box. In other examples of the fifteenth embodiments, the single box is made from cardboard. In other examples of the fifteenth embodiments, the at least two concentrate containers are cylindrical containers.
According to sixteenth embodiments, the disclosed subject matter includes a system for the preparation of sterile peritoneal dialysis fluid. It includes a disposable fluid circuit with a pumping tube segment and multiple valve segments. The peritoneal dialysis solution admixer/cycler dialysis treatment device includes at least one pumping actuator shaped to engage the at least one pumping tube segment, and has multiple valve actuators positioned to engage the valve segments. A first of the multiple valve segments is connected to a fluid inlet. The disposable fluid circuit has a sterilizing filter connected between the first of the multiple valve segments and the fluid inlet. The system has a water source such as a water purifier or containers of pure water. The system has a first concentrate container with sufficient concentrate for the preparation of enough peritoneal dialysis solution to perform multiple peritoneal dialysis treatments, each peritoneal dialysis treatment including multiple fill/drain cycles. A flow control module connects the first concentrate container and the water source to the fluid inlet and controls flow such that a selected one of water and concentrate can be pumped through the fluid inlet while excluding an unselected one of concentrate and water. The disposable fluid circuit has an integrally-attached mixing container sized to hold sufficient peritoneal dialysis solution for at least a single fill/drain cycle. The peritoneal dialysis solution admixer/cycler dialysis treatment device has a programmable controller programmed to control the pumping actuator to pump concentrate and water into the mixing container to make a batch of peritoneal dialysis fluid and subsequently to perform a fill/drain cycle that includes draining spent peritoneal dialysis solution and pumping a fill of the peritoneal dialysis solution from the mixing container.
Other examples of the sixteenth embodiments may include a second concentrate container that is connected by the flow control module to the fluid circuit.
Other examples of the sixteenth embodiments may include a second concentrate container that has concentrate for the preparation of enough peritoneal dialysis solution to perform multiple peritoneal dialysis treatments, each such peritoneal dialysis treatment including multiple fill/drain cycles.
In other examples of the sixteenth embodiments, the flow control module has a primary connector for the first concentrate container to be used every multiple peritoneal dialysis treatments and a secondary connector to which the fluid inlet is connected once every peritoneal dialysis treatment. In other examples of the sixteenth embodiments, the sterilizing filter has an air port to allow a membrane of the sterilizing filter to be pressure tested, and the controller is programmed to test the sterilizing filter membrane by applying pressure to the air port and measuring the pressure after pumping water therethrough. In other examples of the sixteenth embodiments, the controller generates an alarm signal responsively to a result of a test of the sterilizing filter membrane if the test indicates a loss of integrity of the sterilizing filter membrane.
According to seventeenth embodiments, the disclosed subject matter includes a system for the preparation of sterile peritoneal dialysis fluid. It includes a disposable fluid circuit with a pumping tube segment and multiple valve segments. The peritoneal dialysis solution admixer/cycler dialysis treatment device has at least one pumping actuator positioned to engage the at least one pumping tube segment, and multiple valve actuators positioned to engage the valve segments. A first of the multiple valve segments is connected to a fluid inlet. The disposable fluid circuit has a sterilizing filter connected between a fluid inlet connector and the first of the multiple valve segments. A first concentrate container has sufficient concentrate for the preparation of enough peritoneal dialysis solution to perform multiple peritoneal dialysis treatments, each peritoneal dialysis treatment including multiple fill/drain cycles. The disposable fluid circuit has an integrally-attached mixing container sized to hold sufficient peritoneal dialysis solution for at least a single fill/drain cycle. An interconnection module has a primary concentrate connector and a primary water connector. The first concentrate container is replaced by connecting a new first concentrate connector to the primary concentrate connector once every multiple peritoneal dialysis treatments. The interconnection module also has a common secondary connector to which the disposable fluid circuit fluid inlet connector is connected once every peritoneal dialysis treatment. The interconnection module has a valve network controlled by the programmable controller that selects water or concentrate to be drawn by the peritoneal dialysis solution admixer/cycler dialysis treatment device through the common secondary connector. The peritoneal dialysis solution admixer/cycler dialysis treatment device has a programmable controller programmed to control the pumping actuator to pump concentrate and water into the mixing container to make a batch of peritoneal dialysis fluid and subsequently to perform a fill/drain cycle that includes draining spent peritoneal dialysis solution and pumping a fill of the peritoneal dialysis solution from the mixing container.
Other examples of the seventeenth embodiments include a second concentrate container that is replaced by connecting a new second concentrate connector to the primary concentrate connector once every multiple peritoneal dialysis treatments, the interconnection module valve network controlled to select water, the first concentrate, or the second concentrate to be drawn by the peritoneal dialysis solution admixer/cycler dialysis treatment device through the common secondary connector. In other examples of the seventeenth embodiments, the second concentrate container has concentrate for the preparation of enough peritoneal dialysis solution to perform multiple peritoneal dialysis treatments, each peritoneal dialysis treatment including multiple fill/drain cycles, wherein first and second concentrate inlets are connected to the first and second concentrate containers by a double connector, the double connector making connections for the first concentrate inlet connector and the second concentrate inlet simultaneously to the first and second concentrate containers, the interconnection module selectively connecting the first and second concentrate inlets to the primary concentrate connector. In other examples of the seventeenth embodiments, the programmable controller is programmed to calculate and store data representing a volume, and data representing a composition of fluid remaining in a portion of the valve network after flowing fluid by the peritoneal dialysis solution admixer/cycler dialysis treatment device, and to control the pump responsively to the data representing a volume of water or concentrate, whereby the proportions of solutes and water ultimately generated in the mixing container includes residual volumes remaining at times in the fluid circuit which are accounted for by the controller.
According to eighteenth embodiments, the disclosed subject matter includes a method of performing a peritoneal dialysis treatment. The method includes drawing a concentrate and water through a sterilizing filter in predefined quantities to make a sufficient quantity of peritoneal dialysis solution for at least a single fill of a peritoneal dialysis treatment. The drawing includes, using an interconnection module, connecting water and concentrate at different times to a common inlet of a disposable fluid circuit to which the sterilizing filter is integrally attached. The method includes testing the sterilizing filter by means of an air pressure test and using, or preventing use of, the quantity of peritoneal dialysis solution for a peritoneal dialysis fill and drain cycle depending on a result of the testing.
In other eighteenth embodiments, the method may include connecting a long-term concentrate container to the interconnection module once every multiple peritoneal dialysis treatments. In other eighteenth embodiments, the method may include connecting a peritoneal dialysis treatment circuit with the sterilizing filter integrally attached thereto to the interconnection module once every single peritoneal dialysis treatments. In other eighteenth embodiments, the method may include mixing the water and the concentrate. In other eighteenth embodiments, the drawing and the mixing are performed using a single common pump. In other eighteenth embodiments, the drawing is assisted by a separate pump connected to a source of concentrate.
According to nineteenth embodiments, the disclosed subject matter includes a method of making a fluid circuit that has a chamber prefilled with medicament concentrate. The method includes integrally connecting a fluid circuit with a chamber, and connecting a sterilizing filter with the chamber. The integrally connecting and connecting a sterilizing filter may form an assembly with a sealed volume that is separated from the outside environment by walls thereof, a frangible plug in a concentrate outlet line stemming from the chamber, and a membrane of the sterilizing filter. The method includes sterilizing the assembly and sterile-filling the chamber with concentrate through the sterilizing filter, permanently cutting and sealing a line connecting the sterilizing filter and the chamber. The method may include subjecting the fluid circuit and chamber to gamma or e-beam sterilization.
According to twentieth embodiments, the disclosed subject matter includes a fluid circuit for peritoneal dialysis and dialysis solution preparation. A disposable mixing container of polymeric material has a pre-connected fluid circuit. The mixing container and fluid circuit are sealed from an external environment. A concentrate container of polymeric material is pre-connected to the fluid circuit. The concentrate container is sealed from an external environment. The fluid circuit includes a fluid flow director that includes a valve network that has junctions and valve portions that mechanically engage valve actuators to define selectable flow paths in the valve network. The valve network further includes a concentrate line connected to the concentrate container. A water line is terminated by a water line connector. A pair of lines is connected to the mixing container to permit simultaneous flow into, and flow out from, the mixing container. The water line has an in-line sterilizing filter with an air-line attached thereto. The air-line is connected such that air forced through the air-line applies pressure to a membrane of the in-line sterilizing filter to permit an integrity test thereof. The valve network is positioned and held in a cartridge that has a pumping portion supported by a rigid manifold which is hollow and defines at least some of the junctions, and an air-line connecting to a port fixedly attached to the manifold. The manifold is rigid and defines two separate chambers connected by a pumping tube segment.
In variations thereof, the twentieth embodiments include ones in which the air-line is collinear with at least a portion of a respective one of the concentrate and water lines. In variations thereof, the twentieth embodiments include ones in which the valve network is supported by a panel and the manifold is connected to the panel. In variations thereof, the twentieth embodiments include ones in which the valve network is supported by a panel and the manifold is spaced apart from the panel. In variations thereof, the twentieth embodiments include ones in which the air-line is integral with at least a portion of a respective one of the concentrate and water lines. In variations thereof, the twentieth embodiments include ones in which the manifold chamber has pressure sensors integrated therein, one at each end of the pumping tube segment.
In variations thereof, the twentieth embodiments include ones in which the pumping tube segment is straight. In variations thereof, the twentieth embodiments include ones in which the pressure sensor includes a pressure pod with a diaphragm that serves as a portion of a wall of a respective one of the two separate chambers. In variations thereof, the twentieth embodiments include ones in which the respective concentrate line connectors are connected by a frame that supports a portion of the concentrate line. In variations thereof, the twentieth embodiments include ones in which the frame has a window and a portion of the concentrate line passes across the window. In variations thereof, the twentieth embodiments include ones in which the valve network has a drain line. In variations thereof, the twentieth embodiments include ones in which the valve network has a fill/drain line connectable to a peritoneal catheter. In variations thereof, the twentieth embodiments include ones in which the fill/drain line is sealed by a removable end cap. In variations thereof, the twentieth embodiments include ones in which the fill/drain line has a second air-line collinear with the fill/drain line, connected at an end of the fill/drain line to a pressure pod connected to the fill/drain line to measure a pressure therewithin.
In variations thereof, the twentieth embodiments include ones in which the drain and water lines are connected by a frame that supports portions of the drain and water lines. In variations thereof, the twentieth embodiments include ones in which the frame has a window and portions of the drain and water lines pass across the window. In variations thereof, the twentieth embodiments include ones in which the valve portions are supported by a planar element. In variations thereof, the twentieth embodiments include ones in which the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions. In variations thereof, the twentieth embodiments include ones in which the planar element includes a pair of sheets shaped to hold the valve portions in predefined positions, and at least one of the pair of sheets has holes in it to permit valve actuators to contact the valve portions. In variations thereof, the twentieth embodiments include ones in which the valve portions are tube segments. In variations thereof, the twentieth embodiments include ones in which the concentrate line is sealed by a frangible seal. In variations thereof, the twentieth embodiments include ones in which the cartridge includes parallel panels with the valve network sandwiched between them, and the frangible seal held in the cartridge is aligned with windows in at least one of the panels to permit an actuator to fracture them prior to use, thereby allowing the concentrate to flow through the concentrate line. In variations thereof, the twentieth embodiments include ones in which the cartridge includes a single folded panel forming parallel panel portions with the valve network sandwiched between them, and the frangible seal held in the cartridge is aligned with windows in at least one of the panels to permit an actuator to fracture them prior to use thereby allowing the concentrate to flow through the concentrate line. In variations thereof, the twentieth embodiments include ones in which the valve network includes the concentrate line which is sealed by a frangible seal thereby separating the concentrate from the rest of the fluid circuit until the frangible seal is fractured. In variations thereof, the twentieth embodiments include ones with a second sterilizing filter connected in series with the in-line sterilizing filter such that the second and in-line sterilizing filters are separated by a flow channel to prevent grow-through contamination between membranes thereof. In variations thereof, the twentieth embodiments include ones in which the mixing container and concentrate container are defined by two bonded flexible panels along seams that define the mixing container and concentrate container. In variations thereof, the twentieth embodiments include ones in which the seams are a result of thermal welding. In variations thereof, the twentieth embodiments include ones in which the fluid circuit encloses a sterile internal volume.
According to twenty-first embodiments, the disclosed subject matter includes a fluid line connector. At least one thermoplastic tube is supported in a frame such that the at least one thermoplastic tube is accessible from opposite sides of the frame. The frame has an overhanging ridge at one end and at least one connector that is fluidly coupled at an opposite end to the at least one thermoplastic tube. A cap is fitted to the frame to cover the at least one connector. The at least one tube extends through holes in the frame at ends thereof adjacent the overhanging ridge.
In variations thereof, the twenty-first embodiments include ones in which the frame has a recess shaped to engage a détente pin along an elongated side thereof. In variations thereof, the twenty-first embodiments include ones in which the frame has an oval-shaped recess, and the at least one connector is located within the oval-shaped recess. In variations thereof, the twenty-first embodiments include ones in which the cap fits in the oval-shaped recess to define a tortuous path between the at least one connector and an access of the oval-shaped recess. In variations thereof, the twenty-first embodiments include ones in which at least one connector and the at least one thermoplastic tubes are at least two.
According to twenty-second embodiments, the disclosed subject matter includes a connector system in which a connector component has at least one thermoplastic tube supported in a frame such that the at least one thermoplastic tube is accessible from opposite sides of the frame. The frame has an overhanging ridge at one end and at least one connector that is fluidly coupled at an opposite end to the at least one thermoplastic tube. A cap is fitted to the frame to cover the at least one connector. The at least one tube extends through holes in the frame at an end thereof adjacent the overhanging ridge. A fluid supply device has at least one supply connector that mates with the at least one connector. The fluid supply device has a portion shaped to engage the frame to align the at least one thermoplastic tube with a tube cut-and-seal device.
In variations thereof, the twenty-second embodiments include ones in which the cut-and-seal device cuts the at least one thermoplastic tube thereby forming two cut ends and seals it at the two cut ends. The connector component is configured to permit the at least one thermoplastic tube to be withdrawn from the one end leaving the frame and at least one connector in place on the at least one supply connector to cover and protect it from contamination until it is replaced by another connector component. In variations thereof, the twenty-second embodiments include ones in which the frame has a recess shaped to engage a détente pin along an elongated side thereof. In variations thereof, the twenty-second embodiments include ones in which the frame has an oval-shaped recess, and the at least one connector is located within the oval-shaped recess. In variations thereof, the twenty-second embodiments include ones in which the cap fits in the oval-shaped recess to define a tortuous path between the at least one connector and an access of the oval-shaped recess.
According to twenty-third embodiments, the disclosed subject matter includes a fluid preparation method implemented by an admixer under programmatic control of a controller. The controller implements the method. The admixer has, connected thereto, a fluid circuit that includes a mixing container, one or more containers of medicament concentrate, and a source of purified water suitable for peritoneal dialysate. Each of the one or more containers has sufficient medicament concentrate for multiple treatments. The admixer has actuators that engage with the fluid circuit to transport concentrate and water to the mixing container. The method includes flowing purified water and concentrate through the fluid circuit to the mixing container to prepare a medicament in the mixing container by admixing and diluting the medicament concentrate. The flowing includes flowing water and concentrate through at least one sterilizing filter to ensure sterility of the water and concentrate.
In variations thereof, the twenty-third embodiments include ones in which the at least one sterilizing filter is integrally attached to the fluid circuit. In variations thereof, the twenty-third embodiments include ones that include ensuring an integrity of at least one sterilizing filter by testing the at least one sterilizing filter or providing serially-connected redundant sterilizing filters. In variations thereof, the twenty-third embodiments include ones that include using the contents of the mixing container to treat a first patient and thereafter replacing the fluid circuit in preparation for treating the first or a second patient.
According to twenty-fourth embodiments, the disclosed subject matter includes a fluid preparation system. An admixing component receives water and concentrate from sources thereof and mixes them in a mixing container under control of a controller. A drain component is connected to the mixing container through a fluid flow director controlled by the controller to selectively convey fluids from the mixing container to the drain through a fluid channel containing a fluid conductivity measurement sensor. A bypass line has an automatic valve, controlled by the controller, that diverts fluids from fluid flow director directly to the drain without flowing through the fluid conductivity measurement sensor.
In variations thereof, the twenty-fourth embodiments include ones in which the controller is a programmable controller programmed to divert fluids from a source other than the mixing container from the fluid flow director directly to the drain. In variations thereof, the twenty-fourth embodiments include ones in which the source other than the mixing container is a source of cleaning fluid or a source of water. In variations thereof, the twenty-fourth embodiments include ones in which the source other than the mixing container is a source of used dialysate. In variations thereof, the twenty-fourth embodiments include ones in which the source other than the mixing container is a source of cleaning fluid or a source of water.
According to twenty-fifth embodiments, the disclosed subject matter includes a system for generating a dialysis fluid. A fluid admixer with an admixer controller and valve and pumping actuators is controlled by an admixer controller. At least two concentrate containers have concentrate supply connectors. The concentrate containers have sufficient concentrate to perform multiple peritoneal dialysis treatments. Each treatment includes multiple fill/drain cycles. A daily disposable component includes a mixing container of polymeric material with a pre-connected fluid circuit. The mixing container and fluid circuit is sealed from an external environment. The mixing container has a capacity sufficient for a full automated peritoneal dialysis treatment of at least five fill/drain cycles each of at least 1000 ml. The fluid circuit includes a valve network with junctions and valve portions and a pumping portion that mechanically interface with the valve and pumping actuators to define selectable flow paths in the valve network. The valve network further includes a fluid inlet line. The valve network is fluidly connected for flow into and out of the mixing container. The fluid inlet line has at least one in-line sterilizing filter.
In variations thereof, the twenty-fifth embodiments include ones in which the valve network is positioned and held in a cartridge that has a pumping portion supported by a rigid manifold, the rigid manifold is hollow and defining at least some of the junctions. In variations thereof, the twenty-fifth embodiments include ones in which the at least one in-line sterilizing filter includes a testable filter with an air-line, the air-line connecting to a port fixedly attached to the rigid manifold and configured to engage with an air supply port of the fluid admixer upon insertion of the manifold in a slot of the fluid admixer. In variations thereof, the twenty-fifth embodiments include ones in which the rigid manifold defines two separate chambers, the pumping portion includes a pumping tube segment, the pumping tube segment connecting the two separate chambers. In variations thereof, the twenty-fifth embodiments include ones that include a connection platform that mechanically supports the at least two concentrate containers and selectively couples them to the fluid inlet line. In variations thereof, the twenty-fifth embodiments include ones that include a connection platform with a water source and attachments for the at least two concentrate containers, the connection platform has a valve network that fluidly couples the concentrate containers and the water source to the fluid inlet line. In variations thereof, the twenty-fifth embodiments include ones in which the at least one sterilizing filter includes two redundant sterilizing filters in series or an air-line attached to the in-line sterilizing filter, the air-line is connected such that air forced through the air-line applies pressure to a membrane of the in-line sterilizing filter to permit an integrity test thereof the air-lines are each collinear with at least a portion of the fluid inlet line. In variations thereof, the twenty-fifth embodiments include ones in which the air-line is attached along at least a portion of the fluid inlet line. In variations thereof, the twenty-fifth embodiments include ones in which each manifold chamber has pressure sensors integrated therein, one at each end of the pumping tube segment. In variations thereof, the twenty-fifth embodiments include ones in which the pumping tube segment is straight. In variations thereof, the twenty-fifth embodiments include ones in which the pressure sensors include pressure pods, each with a diaphragm that serves as a portion of a wall of a respective one of the two separate chambers. In variations thereof, the twenty-fifth embodiments include ones that include a connection platform, wherein respective concentrate supply connectors are connected to a valve network of the connection platform, the connection platform has a water source connected to the fluid inlet by the connection platform valve network. In variations thereof, the twenty-fifth embodiments include ones in which the valve network has a drain line with at least one conductivity sensor. In variations thereof, the twenty-fifth embodiments include ones that include a connection platform and wherein respective concentrate supply connectors are connected to a valve network of the connection platform, the connection platform has a water source connected to the fluid inlet by the connection platform valve network, the water source has a pump and the connection platform valve network has a pump connected by outlets of the at least two concentrate containers.
According to twenty-sixth embodiments, the disclosed subject matter includes a fluid preparation system with an admixer under programmatic control of an admixing controller. The admixer has connectable to a disposable fluid circuit that includes a mixing container. The fluid circuit is connected by a fluid interface to one or more containers of medicament concentrate, and a pure water source, the pure water source includes a container or treatment plant suitable for providing purified water suitable for peritoneal dialysate. Each of the one or more containers of medicament concentrate has sufficient medicament concentrate for multiple peritoneal dialysis treatments. the admixer is connected to the fluid interface to receive medicament concentrate and water from the pure water source therethrough. the admixer has actuators that engage with the fluid circuit, when connected thereto, to transport concentrate and water to the mixing container. The admixing controller is programmed to flow water and concentrate through the fluid circuit to the mixing container to prepare a medicament in the mixing container by admixing and diluting the medicament concentrate.
In variations thereof, the twenty-sixth embodiments include ones with at least one sterilizing filter positioned in the disposable fluid circuit to filter water and concentrate from the one or more containers of concentrate, wherein the at least one sterilizing filter is integrally attached to the fluid circuit. In variations thereof, the twenty-sixth embodiments include ones in which the fluid interface has a drain component connectable to the fluid circuit by a drain port. In variations thereof, the twenty-sixth embodiments include ones in which the drain component has a conductivity sensor and two selectable channels including a bypass channel that connects the drain port directly to a drain outlet and a conductivity sensor channel connects the drain port to the drain outlet through the conductivity sensor, a selected one of the two selectable channels connecting the drain port and drain outlet being selectable by means of a control valve. In variations thereof, the twenty-sixth embodiments include ones in which the admixing controller selects the selected one of the two selectable channels responsively to a type of fluid or a fluid source. In variations thereof, the twenty-sixth embodiments include ones in which the admixing controller selects the conductivity sensor channel, at times, when the fluid source is the mixing container. In variations thereof, the twenty-sixth embodiments include ones in which the admixing controller selects the bypass channel, at times, when the fluid source is a source of cleaning fluid. In variations thereof, the twenty-sixth embodiments include ones in which the admixing controller selects the bypass channel, at times, when the fluid source is the pure water source. In variations thereof, the twenty-sixth embodiments include ones in which the admixing controller selects the bypass channel, at times, when the fluid source is a source of used dialysate. In variations thereof, the twenty-sixth embodiments include ones in which the fluid interface has a fluid supply network with valves for each of the one or more containers of medicament concentrate, the fluid supply network selectively connecting a selected one of the one or more containers of medicament concentrate to a common concentrate line of the fluid supply network responsively to the admixing controller. In variations thereof, the twenty-sixth embodiments include ones in which the fluid supply network includes a single pump in the common concentrate line. In variations thereof, the twenty-sixth embodiments include ones in which the common concentrate line is connectable to a common fluid inlet of the fluid circuit. In variations thereof, the twenty-sixth embodiments include ones in which the common fluid inlet of the fluid circuit has a sterilizing filter. In variations thereof, the twenty-sixth embodiments include ones in which the at least one sterilizing filter includes two sterilizing filters in series or a testable filter with a port for an application of pressurized air. In variations thereof, the twenty-sixth embodiments include ones in which the fluid interface has a fluid supply network with valves for each of the one or more containers of medicament concentrate and a valve for the pure water source, the fluid supply network selectively connecting a selected one of the one or more containers of medicament concentrate or the pure water source a common fluid line of the fluid supply network responsively to the admixing controller. In variations thereof, the twenty-sixth embodiments include ones in which the fluid supply network includes a single pump in the common fluid line. In variations thereof, the twenty-sixth embodiments include ones in which the common fluid line is connectable to a common fluid inlet of the fluid circuit. In variations thereof, the twenty-sixth embodiments include ones in which the common fluid inlet of the fluid circuit has a sterilizing filter. In variations thereof, the twenty-sixth embodiments include ones that include at least one in-line sterilizing filter positioned in the disposable fluid circuit to filter water and concentrate from the one or more containers of concentrate, wherein the at least one sterilizing filter is integrally attached to the fluid circuit and wherein the sterilizing filter includes two sterilizing filters in series or a testable filter with a port for an application of pressurized air. In variations thereof, the twenty-sixth embodiments include ones in which the fluid interface has a fluid supply network with valves for each of the one or more containers of medicament concentrate and a valve for the pure water source, the fluid supply network selectively connecting a selected one of the one or more containers of medicament concentrate or the pure water source a common fluid line of the fluid supply network responsively to the admixing controller, wherein the pure water source includes a treatment plant with a pump. In variations thereof, the twenty-sixth embodiments include ones in which the fluid supply network includes a single pump in the common fluid line. In variations thereof, the twenty-sixth embodiments include ones in which the common fluid line is connectable to a common fluid inlet of the fluid circuit. In variations thereof, the twenty-sixth embodiments include ones in which the common fluid inlet of the fluid circuit has a sterilizing filter. In variations thereof, the twenty-sixth embodiments include ones in which the sterilizing filter includes two sterilizing filters in series or a testable filter with a port for an application of pressurized air. In variations thereof, the twenty-sixth embodiments include ones in which the fluid interface has a fluid supply network with channels for each of the one or more containers of medicament concentrate and a channel for the pure water source, each of the channels connecting to the fluid circuit connected to the admixing controller, the admixing controller selecting, at a time, one of the channels for transport of a selected concentrate or water to the mixing container by actuation of the actuators. In variations thereof, the twenty-sixth embodiments include ones in which each of the channels has a sterilizing filter. In variations thereof, the twenty-sixth embodiments include ones in which the sterilizing filter includes two sterilizing filters in series or a testable filter with a port for application of pressurized air.
According to twenty-seventh embodiments, the disclosed subject matter includes a fluid circuit for dialysis solution preparation. A disposable mixing container of polymeric material has a pre-connected fluid circuit, the mixing container and fluid circuit is sealed from an external environment. A concentrate container of polymeric material is pre-connected to the fluid circuit and fluidly coupled therewith except for has a frangible seal between the concentrate container and a rest of the fluid circuit. The concentrate container and fluid circuit are sealed from an external environment. The fluid circuit includes a valve network that has junctions and valve portions that mechanically interface with valve actuators to define selectable flow paths in the valve network. The valve network further includes a concentrate line connected to the concentrate container, a water line terminated by a water line connector, and at least one line connected to the mixing container to permit simultaneous flow into, and flow out from, the mixing container. A water inlet line in the valve network fluidly coupled to the mixing container, the water inlet line having an in-line sterilizing filter. In the twenty-seventh embodiments and in others disclosed herein, the sterile filter is positioned in the water line. In use, because of the pumping directions and valve settings, the water line may be the only line by which fluid may enter the mixing container via the fluid network from the outside world. This is not guaranteed by the form of the fluid circuit but this is enabled by it in providing the sterilizing filter on the water connection. Other connection such as the patient line, drain, and sample lines may be provided but these only permit flow out of the fluid circuit, except for the flow of spent peritoneal dialysis fluid which is generally safe from contamination as long as the patient is healthy and sterile practice is properly followed in performing a treatment. An example of the twenty-seventh embodiment is the fluid circuit 200. It can be verified that the only other fluids required for adding to the mixing container to make a batch of dialysis fluid are the concentrates and those are already sterile-sealed in the fluid circuit. Thus, by providing a sterile filter 115 on the water line, no risk of touch contamination is present except for the patient line, when the admixer/cycler uses the fluid circuit.
In variations thereof, the twenty-seventh embodiments include ones in which the at least one line includes a pair of lines. In variations thereof, the twenty-seventh embodiments include ones in which the valve network is positioned and held in a cartridge that has a pumping portion. In variations thereof, the twenty-seventh embodiments include ones in which the valve network is positioned and held in a cartridge that has a pumping portion supported by a rigid manifold. In variations thereof, the twenty-seventh embodiments include ones in which the manifold has two chambers interconnected by the pumping portion. In variations thereof, the twenty-seventh embodiments include ones in which the manifold two chambers are rigidly connected. In variations thereof, the twenty-seventh embodiments include ones in which the pumping portion includes a pumping tube segment. In variations thereof, the twenty-seventh embodiments include ones in which the valve network includes a manifold and the in-line sterilizing filter has an air-line attached thereto, the air-line is connected such that air forced through the air-line applies pressure to a membrane of the in-line sterilizing filter to permit an integrity test thereof, the air-line connecting to a port fixedly attached to the manifold. In variations thereof, the twenty-seventh embodiments include ones in which the mixing container and concentrate container are defined by two bonded flexible panels along seams to define the mixing container and concentrate container. In variations thereof, the twenty-seventh embodiments include ones in which the seams are integral as formed by welding or adhesive bonding. In variations thereof, the twenty-seventh embodiments include ones in which the fluid circuit encloses a sterile internal volume.
According to twenty-eight embodiments, the disclosed subject matter includes a system for dialysis solution preparation. An admixer has valve and pumping actuators and an admixing controller. A disposable mixing container of polymeric material has a pre-connected fluid circuit. The mixing container and fluid circuit are sealed from an external environment. A concentrate container of polymeric material is pre-connected to the fluid circuit and fluidly coupled therewith except for has a frangible seal between the concentrate container and a rest of the fluid circuit. The concentrate container and fluid circuit are sealed from an external environment (using connector seal caps as necessary). The fluid circuit includes a valve network that has pumping and valve portions that mechanically interface with the valve and pumping actuators to transport fluid along selected channels in the valve network. The valve network further includes a concentrate line connected to the concentrate container, a water line terminated by a water line connector, and at least one line connected to the mixing container to permit simultaneous flow into, and flow out from, the mixing container. A water inlet line in the valve network fluidly coupled to the mixing container, the water inlet line having an in-line sterilizing filter.
In variations thereof, the twenty-eighth embodiments include ones in which the admixer has a seal breaker that engages with the frangible seal, the admixing controller breaking the frangible seal before transporting concentrate through the fluid circuit. In variations thereof, the twenty-eighth embodiments include ones in which the at least one line includes a pair of lines. In variations thereof, the twenty-eighth embodiments include ones in which the valve network is positioned and held in a cartridge that has a pumping portion. In variations thereof, the twenty-eighth embodiments include ones in which valve network is positioned and held in a cartridge that has a pumping portion supported by a rigid manifold. In variations thereof, the twenty-eighth embodiments include ones in which the manifold has two chambers interconnected by the pumping portion. In variations thereof, the twenty-eighth embodiments include ones in which the manifold two chambers are rigidly connected. In variations thereof, the twenty-eighth embodiments include ones in which the pumping portion includes a pumping tube segment. In variations thereof, the twenty-eighth embodiments include ones in which the in-line sterilizing filter has an air-line attached thereto, the air-line is connected such that air forced through the air-line applies pressure to a membrane of the in-line sterilizing filter to permit an integrity test thereof, the air-line connecting to a port fixedly attached to the manifold. In variations thereof, the twenty-eighth embodiments include ones in which the mixing container and concentrate container are defined by two bonded flexible panels along seams to define the mixing container and concentrate container. In variations thereof, the twenty-eighth embodiments include ones in which the seams are integral as formed by welding or adhesive bonding. In variations thereof, the twenty-eighth embodiments include ones in which the system encloses a sterile internal volume.
According to twenty-ninth embodiments, the disclosed subject matter includes a system for dialysis solution preparation. An admixer has valve actuators, a pumping actuator, and an admixing controller. A disposable mixing container of polymeric material is pre-connected by a mixing container line to a fluid circuit. The mixing container and fluid circuit are sealed from an external environment and the fluid circuit has a valve network. One or more concentrate containers and a source of purified water are connected to the valve network. The valve network defines selectable flow paths to convey water and concentrate into the mixing container and permit flow of contents of the mixing container out of the mixing container. The valve network has pumping and valve portions that mechanically interface with the valve and pumping actuators to transport fluid along selected channels in the valve network to mix water and concentrate in the mixing container. The mixing container line is connected to a header tube with multiple openings to distribute flow over an extended length thereof to the mixing container. The admixing controller controls the pumping actuator pump to mix fluid in the mixing container by pumping fluid into and out of the mixing container.
In variations thereof, the twenty-ninth embodiments include ones in which a header tube receives flow from the mixing container at multiple locations along the header tube. In variations thereof, the twenty-ninth embodiments include ones in which the header tube has a plurality of openings distributed along a major length thereof. In variations thereof, the twenty-ninth embodiments include ones in which the mixing container line is used for incoming flow only and outgoing flow is conveyed from the mixing container through a further line connected to the valve network. In variations thereof, the twenty-ninth embodiments include ones in which the fluid circuit has an accumulator and the pumping actuator pumps fluid back and forth between the mixing container and the accumulator to mix the contents of the mixing container.
According to thirtieth embodiments, the disclosed subject matter includes a fluid circuit for dialysis solution preparation. A disposable mixing container of polymeric material is pre-connected by a mixing container line to a fluid circuit. The mixing container and fluid circuit are sealed from an external environment. The fluid circuit has a valve network. At least one fluid line has an inlet connection for receiving concentrate and purified water into the valve network. The valve network defining selectable flow paths to convey water and concentrate into the mixing container and permit flow of contents of the mixing container out of the mixing container. The valve network has pumping and valve portions that can mechanically interface with valve and pumping actuators to define the selectable flow paths in the valve network and permit pumping therethrough to mix water and concentrate in the mixing container. The mixing container line is connected to a header tube with multiple openings to distribute flow over an extended length thereof to the mixing container.
In variations thereof, the thirtieth embodiments include ones in which the mixing container header tube receives flow from the mixing container at multiple locations along the header tube. In variations thereof, the thirtieth embodiments include ones in which the fluid circuit includes an accumulator fluidly connected to the mixing container with the pumping portion between the mixing container and accumulator to permit the pumping of fluid therebetween to perform mixing.
In variations thereof, the thirtieth embodiments include ones in which the header tube has a plurality of openings distributed along a major length thereof. In variations thereof, the thirtieth embodiments include ones in which the mixing container line is used for incoming flow only and outgoing flow is conveyed from the mixing container through a further line connected to the valve network.
According to thirty-first embodiments, the disclosed subject matter includes a connector system with a connector component that has at least one thermoplastic tube supported in a frame such that the at least one thermoplastic tube is accessible from opposite sides of the frame. The frame has a first at least one male and/or female connector that is fluidly coupled at an end of the at least one thermoplastic tube. A complementary connector has a second at least one male and/or female connector that fits the first at least one male or female connector. A pin on one of the complementary connector or the frame is adjacent a respective one of the first and second male and/or female connector. There is a slot on the other of the complementary connector or the frame that is sized and positioned to receive the pin.
In variations thereof, the thirty-first embodiments include ones in which a cap that is fitted to the frame to cover the at least one connector. In variations thereof, the thirty-first embodiments include ones in which the at least one thermoplastic tube extends through one or more holes in the frame at an end thereof. In variations thereof, the thirty-first embodiments include ones in which the frame has an overhanging ridge adjacent the first at least one male and/or female connector. In variations thereof, the thirty-first embodiments include ones that include a fluid supply device with at least one supply connector that mates with the at least one connector, the fluid supply device has a portion shaped to engage the frame to align the at least one thermoplastic tube with a tube cut-and-seal device. In variations thereof, the thirty-first embodiments include ones in which the cut-and-seal device cuts the at least one thermoplastic tube thereby forming two cut ends and seals it at the two cut ends, the connector component is configured to permit the at least one thermoplastic tube to be withdrawn from the one end leaving the frame and at least one connector in place on the at least one supply connector to cover and protect it from contamination until it is replaced by another connector component. In variations thereof, the thirty-first embodiments include ones in which the frame has a recess shaped to engage a détente pin along an elongated side thereof. In variations thereof, the thirty-first embodiments include ones in which the frame has an oval-shaped recess, the at least one connector is located within the oval-shaped recess. In variations thereof, the thirty-first embodiments include ones in which the cap fits in the oval-shaped recess to define a tortuous path between the at least one connector and an access of the oval-shaped recess. In variations thereof, the thirty-first embodiments include ones in which at least one connector and the at least one thermoplastic tube are at least two. In variations thereof, the thirty-first embodiments include ones in which the frame has a recess shaped to engage a détente pin along an elongated side thereof. In variations thereof, the thirty-first embodiments include ones in which the frame has an oval-shaped recess, the at least one connector is located within the oval-shaped recess. In variations thereof, the thirty-first embodiments include ones in which the cap fits in the oval-shaped recess to define a tortuous path between the at least one connector and an access of the oval-shaped recess. In variations thereof, the thirty-first embodiments include ones in which the at least one connector and the at least one thermoplastic tube are at least two.
According to thirty-second embodiments, the disclosed subject mater includes a system for preparing dialysis treatment fluid. An integrally interconnected fluid circuit includes a mixing container with a pre-connected fluid circuit. The mixing container and fluid circuit are sealed from an external environment. The fluid circuit includes a valve network that has junctions and valve portions that mechanically interface with valve actuators to define selectable flow paths in the valve network. The valve network further includes a pumping portion and a fluid inlet line with a connector for connection to a fluid source. The fluid inlet line is fluidly connected to the mixing container by the pumping portion. The valve network is fluidly connects the mixing container to the fluid inlet. The fluid inlet line has at least one in-line sterilizing filter includes one of a pair of spaced sterilizing filters and a testable filter with an air-line.
In variations thereof, the thirty-second embodiments include ones in which the mixing container is principally of polymeric sheet material. In variations thereof, the thirty-second embodiments include ones in which the valve portions include tube segments that are flexible to permit closure by clamps. In variations thereof, the thirty-second embodiments include ones that include a manifold connected to the valve network and defining at least some of the junctions, the manifold has integrated pressure sensors. In variations thereof, the thirty-second embodiments include ones in which the manifold supports the pumping portion between the pressure sensors. In variations thereof, the thirty-second embodiments include ones in which the pumping portion is a straight tube supported at opposite ends thereof by the manifold. In variations thereof, the thirty-second embodiments include ones in which the manifold has connectors for the air-line.
In variations thereof, the thirty-second embodiments include ones in which the sterile filter is a testable sterile filter with an air pressure line, the air pressure line is connected to an air pump. In variations thereof, the thirty-second embodiments include ones in which the mixing container has two mixing container lines. In variations thereof, the thirty-second embodiments include ones in which the mixing container has single mixing container line. In variations thereof, the thirty-second embodiments include ones in which the valve network is connected to an accumulator that is connected by the pumping portion to the mixing container. In variations thereof, the thirty-second embodiments include ones in which the fluid inlet is connected to at least two concentrate containers, the concentrate containers have a capacity sufficient to store enough concentrate to perform multiple peritoneal dialysis treatments, where each treatment includes multiple fill/drain cycles. In variations thereof, the thirty-second embodiments include ones in which the fluid inlet is connected to a water source. In variations thereof, the thirty-second embodiments include ones in which a first of the at least two concentrate containers contains an osmotic agent and the second of the concentrate containers containing electrolytes. In variations thereof, the thirty-second embodiments include ones that include a peritoneal dialysis admixer/cycler with a controller connected to control valve actuators arranged to engage the valve portions and a pumping actuator arranged to receive the pumping portion when the fluid circuit is attached thereto. In variations thereof, the thirty-second embodiments include ones in which the controller is of a programmable type that stores a program to automatically perform a pressure test of the sterile filter filling the mixing container with a fluid. In variations thereof, the thirty-second embodiments include ones that include a peritoneal dialysis admixer/cycler with a controller connected to control valve actuators arranged to engage the valve portions and a pumping actuator arranged to receive the pumping portion when the fluid circuit is attached thereto, wherein the controller is of a programmable type that stores a program to automatically detect the replacement of the fluid circuit and responsively thereto, to determine whether a remaining quantity of the at least two concentrates is sufficient to mix sufficient peritoneal dialysis fluid for a treatment. In variations thereof, the thirty-second embodiments include ones that include a peritoneal dialysis admixer/cycler with a controller that controls a pumping actuator in engagement with the pumping portion, the controller controlling the pumping actuator to mix fluid in the mixing container by continuously circulating fluid with the pump through the valve network and the mixing container through the mixing container lines.
In variations thereof, the thirty-second embodiments include ones that include a peritoneal dialysis admixer/cycler with a controller that controls a pumping actuator in engagement with the pumping portion, the controller controlling the pumping actuator to mix fluid in the mixing container by intermittently exchanging fluid with the pump or an accumulator connected to the valve network. In variations thereof, the thirty-second embodiments include ones in which fluid circuit has a double connector carrying the fluid inlet line and a drain line, the drain line is connected to the valve network, the double connector has a frame that exposes the fluid inlet and drain lines on opposing sides thereof. In variations thereof, the thirty-second embodiments include ones in which the manifold has at least one manifold chamber connected to a sample port, the at least one sample port is controlled by one of the valve actuators responsively to the controller. In variations thereof, the thirty-second embodiments include ones that include a manifold connected to the valve network and defining at least some of the junctions, wherein the fluid circuit has a sample line, a patient fill line, a patient drain line, and drain line connected to the manifold. In variations thereof, the thirty-second embodiments include ones in which the two mixing container lines, the sample line, the fluid inlet line, the patient fill line, the patient drain line, stem from the manifold. In variations thereof, the thirty-second embodiments include ones in which the two mixing container lines, the sample line, the fluid inlet line, the patient fill line, the patient drain line are parallel and adjacent to the manifold and pass along a planar support. In variations thereof, the thirty-second embodiments include ones in which the planar support has windows to permit access to pinch valve actuators. In variations thereof, the thirty-second embodiments include ones in which the planar support, manifold and parallel lines form a generally planar cartridge that can be inserted in a slot. In variations thereof, the thirty-second embodiments include ones in which the controller performs a peritoneal dialysis treatment using the mixing container. In variations thereof, the thirty-second embodiments include ones in which the controller detects an attachment of a new fluid circuit. In variations thereof, the thirty-second embodiments include ones that include a peritoneal dialysis admixer/cycler with a controller that controls a pumping actuator and valve actuators in a receiver into which the insertion of the cartridge, when inserted therein, aligns the pumping actuator, pinch valve actuators, an air sensor, air pump connectors, and pressure transducers with respective portions of the cartridge.
In variations thereof, the thirty-second embodiments include ones in which the patient fill line and patient drain line join via a junction. In variations thereof, the thirty-second embodiments include ones in which the peritoneal dialysis admixer/cycler includes a cycler. In variations thereof, the thirty-second embodiments include ones in which the fluid source includes a connection platform with concentrates and a water source. In variations thereof, the thirty-second embodiments include ones in which the water source includes a purification plant with a pump upstream of the fluid inlet. In variations thereof, the thirty-second embodiments include ones in which the connection platform has a valve array to define flow paths selectively indicated by the controller to connect a selected one of the concentrates or water to the fluid inlet line. In variations thereof, the thirty-second embodiments include ones in which the connection platform has a controller that receives commands from the peritoneal dialysis admixer/cycler. In variations thereof, the thirty-second embodiments include ones in which the connection platform valve array includes a concentrate valve for each of multiple concentrates and a water valve for the water source. In variations thereof, the thirty-second embodiments include ones in which the water source includes a water purification plant with a pump and the water valve is located at an outlet of the water purification, an outlet of the water valve leading to a junction connects a common concentrate line with a pump to a fluid outlet that connects to the fluid inlet, the common concentrate line is connected to the concentrate containers. In variations thereof, the thirty-second embodiments include ones in which the peritoneal dialysis admixer/cycler mixes concentrate and water by commanding the connection platform to set the valve array to select each fluid for transport to the mixing container.
In variations thereof, the thirty-second embodiments include ones in which the peritoneal dialysis admixer/cycler uses contents of the mixing container to perform an automated peritoneal dialysis treatment. In variations thereof, the thirty-second embodiments include ones that include a flow diverter connected to the mixing container line and configured to cause ingoing fluid to enter mixing container at a different location or to be projected to a different location by a nozzle than where outgoing flow exits the mixing container. In variations thereof, the thirty-second embodiments include ones that include a header tube in the mixing container that is configured to distribute ingoing fluid from multiple openings in the mixing container. In variations thereof, the thirty-second embodiments include ones in which the valve network is positioned and held in a cartridge, the pumping portion is supported by a rigid manifold, the manifold is hollow and defining at least some of the junctions. In variations thereof, the thirty-second embodiments include ones in which the manifold has two separate chambers connected by a pumping tube segment. In variations thereof, the thirty-second embodiments include ones in which the manifold has two separate chambers connected for flow communication. In variations thereof, the thirty-second embodiments include ones in which the at least one in-line sterilizing filter includes two redundant sterilizing filters in series. In variations thereof, the thirty-second embodiments include ones in which the in-line sterilizing filter is testable by means of air pressure applied to an air-line attached thereto, the air-line is attached along at least a portion of the fluid inlet line. In variations thereof, the thirty-second embodiments include ones in which the fluid circuit contains no fluids. In variations thereof, the thirty-second embodiments include ones in which the concentrate containers have sufficient concentrate to form at least 35, 40, 50, 65, 80, or 100 liters of ready-to-use dialysate. In variations thereof, the thirty-second embodiments include ones in which the mixing container has a capacity of no more than 15, 20, 25, or 30 liters.
In any of the embodiments, any of the pumps may be, or include, any of a variety of types including peristaltic pumps, diaphragm pumps, screw pumps, gear pumps, centrifugal pumps, turbine pumps, syringe pumps, or piston pumps. The foregoing is a list of examples and is not intended to limit the scope of the present disclosure or the claims below.
In any of the embodiments, the containers of concentrate may be replaced with online sources of concentrate such as admixing plants in a large-scale installation that mixes component ingredients to form concentrates and provides them from a fixed connector. In any of the embodiments, other sources of fluids may be connected to the fluid flow director embodiments described herein. For example, cleaning fluids, reference testing fluids for calibrating the conductivity sensor or sensors, sample fluids, and fluids for testing membranes such as air. In any of the embodiments, such other fluids may flow through various parts of the fluid circuit including the drain as described with reference to other fluids.
As the term is used herein, “flow director” is a fluid circuit and associated actuators effective for selectively creating flow paths and moving fluids through the flow paths in order to connect fluid channels or vessels including those connected to sources and consumers, repositories, or other receiving elements. A “fluid circuit” is may be any line or branching element and may contain vessels, chambers, sensor portions, actuator portions, or any other type of fluid confining and controlling element.
Any embodiment which recites or shows tubes as portions of a fluid circuit, fluid channel, or other equivalent may have instead other types of fluid channel elements such as channels defined in a casting with a bonded film layer to close the channels, panels with welded patterns to form fluid channels, non-round ducts, or other types of elements. The disclosed tubes may be replaced with such alternative elements to form additional embodiments.
Any embodiment which identifies peritoneal dialysis fluid may be modified to form additional embodiments by replacing the components identified with that particular fluid with corresponding fluids to form other medicaments.
Any component or element identified herein as “disposable” may be sterile. Sterility may be readily provided and assured at a time of use, by providing components as disposable elements as is known in the relevant field of medical devices.
As used herein, “pre-connected” or “pre-connected” may refer to the integral combination of elements or to their connection in such a manner as to form a sterile boundary or permit the provision of a sterile boundary around their interior. For example, if a connection of connectors of two elements is made (i.e., they are pre-connected or pre-connected) and the connected elements are sterilized as a unit thereafter, the pre-connected or pre-connected elements may protect against the touch contamination that would be required if the corresponding connection were made in the field, for example. When elements are integral they may provide the same benefit. The terms “pre-connected” or “pre-connected” have the same meaning as used herein.
As the terms are used herein, electrolyte concentrate may include various ionic species as well as non-ionic species as required. As used herein, osmotic agent concentrate may include any osmotic agent such as glucose or dextrose and may include other species including ionic species that may be characterized by the term “electrolytes.”
Any of the embodiments expressly limited to “peritoneal dialysis fluid” may be modified to form additional embodiments by substitution of the term “dialysate” and making appropriate substitutions for the constituents. Any embodiments limited to multiple concentrates, including two, may be changed to employ a single concentrate that is diluted to form a ready-to-use medicament.
Any of the valves or pumps recited herein may be substituted for any of a variety of types of flow directing and fluid conveying devices. For example a variety of pump and valve types are known and may be substituted for those described herein. Variations based on substitutions of these elements may be made to form additional embodiments.
As the term is used herein, “in-line” means that an element is in a flow path. For example, a flow channel with an in-line sterilizing filter is such that fluid flowing in the flow channel is filtered by the in-line filter.
A port is any transition for a fluid conveyance such as a channel, tube, integral connection, or connector. Any recitation of “port” may be replaced with the term “connector” to form variations of the disclosed embodiments.
As used herein, a window is any opening in a curved or flat element. A drain is any outlet to an external element and may include a storage vessel.
Any sterilizing filter may be embodied as a channel blocked by a microporous membrane. Such a microporous membrane may have pores whose maximum size is no greater than a minimum pathogen size. Known threshold pore sizes are, for example, 0.2 microns.
Any embodiment element identified with the term “daily” may be changed by substitution of other time intervals to form additional embodiments.
Integral or integrally attached refers to elements that are formed of a single piece or bonded together so as to create a single unit. Elements identified as integral may be changed to identify them as “connected” or “attached” to define additional embodiments.
As used herein, a “source” is any container or plant capable of supplying a recited fluid. A sink is any destination for a fluid such as a container, a consuming device, or a drain.
As user herein, a “line” is tube or other type of fluid channel. In any of the embodiments, lines may be tubes such as polymer tubing commonly used for medical disposable devices.
A “recess” is any concavity. A recess has two ends, an “access” which is the open end, and a “blind end,” which is the closed end.
Any détente mechanism identified herein may be substituted with any type of frictional or interference-based mechanism for locking or restraining one element relative to another to form additional embodiments.
It will be appreciated that the modules, processes, systems, and sections described above can be implemented in hardware, hardware programmed by software, software instruction stored on a non-transitory computer readable medium, or a combination of the above. For example, a method for preparing a peritoneal dialysis treatment fluid and/or treating a patient can be implemented, for example, using a processor configured to execute a sequence of programmed instructions stored on a non-transitory computer readable medium. For example, the processor can include, but not be limited to, a personal computer or workstation or other such computing system that includes a processor, microprocessor, microcontroller device, or is comprised of control logic including integrated circuits such as, for example, an Application Specific Integrated Circuit (ASIC). The instructions can be compiled from source code instructions provided in accordance with a programming language such as Java, C++, C #.net or the like. The instructions can also comprise code and data objects provided in accordance with, for example, the Visual Basic™ language, LabVIEW, or another structured or object-oriented programming language. The sequence of programmed instructions and data associated therewith can be stored in a non-transitory computer-readable medium such as a computer memory or storage device which may be any suitable memory apparatus, such as, but not limited to read-only memory (ROM), programmable read-only memory (PROM), electrically erasable programmable read-only memory (EEPROM), random-access memory (RAM), flash memory, disk drive and the like.
Furthermore, the modules, processes, systems, and sections can be implemented as a single processor or as a distributed processor. Further, it should be appreciated that the steps mentioned above may be performed on a single or distributed processor (single and/or multi-core). Also, the processes, modules, and sub-modules described in the various figures of and for embodiments above may be distributed across multiple computers or systems or may be co-located in a single processor or system. Exemplary structural embodiment alternatives suitable for implementing the modules, sections, systems, means, or processes described herein are provided below.
The modules, processors or systems described above can be implemented as a programmed general purpose computer, an electronic device programmed with microcode, a hard-wired analog logic circuit, software stored on a computer-readable medium or signal, an optical computing device, a networked system of electronic and/or optical devices, a special purpose computing device, an integrated circuit device, a semiconductor chip, and a software module or object stored on a computer-readable medium or signal, for example.
Embodiments of the method and system (or their sub-components or modules), may be implemented on a general-purpose computer, a special-purpose computer, a programmed microprocessor or microcontroller and peripheral integrated circuit element, an ASIC or other integrated circuit, a digital signal processor, a hardwired electronic or logic circuit such as a discrete element circuit, a programmed logic circuit such as a programmable logic device (PLD), programmable logic array (PLA), field-programmable gate array (FPGA), programmable array logic (PAL) device, or the like. In general, any process capable of implementing the functions or steps described herein can be used to implement embodiments of the method, system, or a computer program product (software program stored on a non-transitory computer readable medium).
Furthermore, embodiments of the disclosed method, system, and computer program product may be readily implemented, fully or partially, in software using, for example, object or object-oriented software development environments that provide portable source code that can be used on a variety of computer platforms. Alternatively, embodiments of the disclosed method, system, and computer program product can be implemented partially or fully in hardware using, for example, standard logic circuits or a very-large-scale integration (VLSI) design. Other hardware or software can be used to implement embodiments depending on the speed and/or efficiency requirements of the systems, the particular function, and/or particular software or hardware system, microprocessor, or microcomputer being utilized. Embodiments of the method, system, and computer program product can be implemented in hardware and/or software using any known or later developed systems or structures, devices and/or software by those of ordinary skill in the applicable art from the function description provided herein and with a general basic knowledge of control system, fluid handling systems, peritoneal dialysis treatment, such as a peritoneal dialysis treatment, and/or computer programming arts.
Moreover, embodiments of the disclosed method, system, and computer program product can be implemented in software executed on a programmed general-purpose computer, a special-purpose computer, a microprocessor, or the like.
System 1000 includes a computer 1002 such as a personal computer or workstation or other such computing system that includes a processor 1006. However, alternative embodiments may implement more than one processor and/or one or more microprocessors, microcontroller devices, or control logic including integrated circuits such as ASIC.
Computer 1002 further includes a bus 1004 that provides communication functionality among various modules of computer 1002. For example, bus 1004 may allow for communicating information/data between processor 1006 and a memory 1008 of computer 1002 so that processor 1006 may retrieve stored data from memory 1008 and/or execute instructions stored on memory 1008. In one embodiment, such instructions may be compiled from source code/objects provided in accordance with a programming language such as Java, C++, C #, .net, Visual Basic™ language, LabVIEW, or another structured or object-oriented programming language. In one embodiment, the instructions include software modules that, when executed by processor 1006, provide renal replacement therapy functionality according to any of the embodiments disclosed herein.
Memory 1008 may include any volatile or non-volatile computer-readable memory that can be read by computer 1002. For example, memory 1008 may include a non-transitory computer-readable medium such as ROM, PROM, EEPROM, RAM, flash memory, disk drive, etc. Memory 1008 may be a removable or non-removable medium.
Bus 1004 may further allow for communication between computer 1002 and a display 1018, a keyboard 1020, a mouse 1022, and a speaker 1024, each providing respective functionality in accordance with various embodiments disclosed herein, for example, for configuring a peritoneal dialysis treatment for a patient and monitoring a patient during a peritoneal dialysis treatment.
Computer 1002 may also implement a communication interface 1010 to communicate with a network 1012 to provide any functionality disclosed herein, for example, for alerting a healthcare professional and/or receiving instructions from a healthcare professional, reporting patient/device conditions in a distributed system for training a machine learning algorithm, logging data to a remote repository, etc. Communication interface 1010 may be any such interface known in the art to provide wireless and/or wired communication, such as a network card or a modem.
Bus 1004 may further allow for communication with a sensor 1014 and/or an actuator 1016, each providing respective functionality in accordance with various embodiments disclosed herein, for example, for measuring signals indicative of a patient/device condition and for controlling the operation of the device accordingly. For example, sensor 1014 may provide a signal indicative of a viscosity of a fluid in a fluid circuit in a renal replacement therapy device, and actuator 1016 may operate a pump that controls the flow of the fluid responsively to the signals of sensor 1014.
In any and all of the foregoing disposable fluid circuits, the components may be integrally-attached, meaning the components may be permanently bonded or otherwise locked together as delivered for use except for removable caps on inlets and outlets. In embodiments, only a single cap may be required to connect one or more concentrate inlets and a single cap may be required to connect a peritoneal dialysis catheter to the integrally-attached fill/drain line. This helps to ensure that a fluid circuit as delivered will not be contaminated by making multiple connections.
Note that in any of the embodiments that include pressure testing of a sterilizing filter, the pressure testing may be performed by applying pressurized air to one side of the filter membrane, fixing the pressurized volume, for example by halting a positive displacement pump, and sampling the pressure over time to acquire a pressure decay curve. Alternatively, a bubble point test may be employed. In yet further embodiments, any other known type of filter integrity test may be employed in addition or as an alternative.
Note that any of the controllers may be formed by multiple controllers or consolidated in a single device, such as an embedded system. The controllers may also include driver circuits and final-controllers, A/D circuits, and other elements to provide the recited functions according to methods and systems known in the art.
The term peritoneal dialysis treatment refers to an automated peritoneal dialysis APD that includes multiple fill and drain cycles. In embodiments, APD is performed at night over an 7-12 hour period. In embodiments, APD is performed during the day. A peritoneal dialysis treatment may include the generation and fill of a last fill that is different from the prescription of the multiple fill/drain cycles over the majority of the APD. The fill volumes for APD can be adjusted as can the dwell time (time between fill and drain) and the number of fill/drain cycles. In embodiments, fill volumes may be 500 ml., 1000 ml., 1500 ml., 2000 ml., 2500 ml., 3000 ml. The long term (or weekly) concentrate containers contain sufficient concentrate to make multiple mixing containers-full of ready-to-use peritoneal dialysis fluid. That is, the long term concentrate containers have sufficient concentrate for multiple APD treatments. In embodiments, the long term concentrate containers are exchanged every several days, for example, weekly. The short term fluid circuit with a pre-connected mixing container is used for a single treatment and after its mixing container contents are exhausted and a treatment is finished, it is removed. At the beginning of a next treatment, the fluid circuit with a new mixing container is connected to the peritoneal dialysis admixer/cycler. Since APD treatments are frequently done on a daily basis, the short term fluid circuit with the pre-connected mixing container may be referred conveniently as a daily fluid circuit. That is, the daily fluid circuit is used for a single peritoneal dialysis treatment and has a mixing container whose capacity is sufficient for a single APD but not more than one treatment. Note that in embodiments, an additional fill may be generated by a daily disposable component for use in continuous ambulatory peritoneal dialysis (CAPD) after an APD treatment, for example.
In any of the embodiments, the peritoneal dialysis solution admixer/cycler controller may be programmed to receive indications of several events as it sequences its operations. For example, a signal may be generated either automatically or by user input that one or both of the long term concentrate container is replaced. Such a signal may be generated automatically by an electrical switch (not shown) connected to a latch 286 (
In any of the embodiments, the volume of the long term concentrate containers may be at least sufficient to form 35 liters of ready-to-use peritoneal dialysis solution. In any of the embodiments, the volume of the long term concentrate containers may be at least sufficient to form 40 liters of ready-to-use peritoneal dialysis solution. In any of the embodiments, the volume of the long term concentrate containers may be at least sufficient to form 50 liters of ready-to-use peritoneal dialysis solution. In any of the embodiments, the volume of the long term concentrate containers may be at least sufficient to form 65 liters of ready-to-use peritoneal dialysis solution. In any of the embodiments, the volume of the long term concentrate containers may be at least sufficient to form 80 liters of ready-to-use peritoneal dialysis solution. In any of the embodiments, the volume of the long term concentrate containers may be at least sufficient to form 100 liters of ready-to-use peritoneal dialysis solution.
In any of the embodiments, the volume of the long term concentrate containers may be at least sufficient to form ready-to-use peritoneal dialysis fluid for 50 fill volumes. In any of the embodiments, the volume of the long term concentrate containers may be at least sufficient to form ready-to-use peritoneal dialysis fluid for 100 fill volumes. In any of the embodiments, the volume of the long term concentrate containers may be at least sufficient to form ready-to-use peritoneal dialysis fluid for 125 fill volumes. In any of the embodiments, the volume of the long term concentrate containers may be at least sufficient to form ready-to-use peritoneal dialysis fluid for 150 fill volumes.
In embodiments disclosed, a testable sterilizing filter is used to filter concentrates and water flowing into a fluid circuit that is replaced daily. In embodiments, the sterilizing filter is integrally connected to the fluid circuit. In embodiments, the sterilizing filter is of a type to which air is applied to perform an integrity test, identified herein as a testable sterilizing filter. In such filters, fluid cannot be drawn through them by a pump because a negative pressure in the fluid channel will draw air into the fluid via a connected air-line. In embodiments disclosed herein, pumps may be arranged to ensure that a positive pressure is maintained on the liquid channel through the testable filter by providing a pump arranged upstream thereof to push fluid. For example, in the disclosed embodiments, a water pump is provided in the water source to push water through filtration stages that purify the water and on the concentrate side of a fluid inlet with the testable filter, upstream of the testable filter, a pump may be provided to draw concentrate and push it through the sterilizing filter. In some cases, it may be possible to draw a low viscosity fluid through a testable filter. Advantageously, however, in some of the disclosed, the viscous concentrates are pushed through the testable filter. Note that as the term is used herein, the term “in-line” does not exclude testable filters with an air port for pressure testing.
In any of the embodiments, including the claims, the fluid circuit may contain no fluids. For example, in claims in which a mixing container is recited, the limitation may be added to any given claim that the fluid circuit contains no fluids, including concentrate, unless explicitly recited that a fluid is contained, for example a concentrate.
Any of the containers recited in the specification or claims may be made of polymeric sheet material, expanded thermoplastic, or other materials. Polymeric sheet material such as used for medical fluid bags may be welded or adhesively bonded to define internal volumes. Containers of sheet material may be collapsed to occupy minimal space when empty. Many of the embodiments in which a fluid circuit is recited may be formed of tubing which is welded or adhesively bonded to the containers of sheet material. The various details of forming such containers and fluid circuits are well known in the art.
It is, thus, apparent that there is provided, in accordance with the present disclosure, methods, devices, and system for preparing fluids, managing fluids, sterilizing fluids, treating patients and other functions. Many alternatives, modifications, and variations are enabled by the present disclosure. Features of the disclosed embodiments can be combined, rearranged, omitted, etc., within the scope of the invention to produce additional embodiments. Furthermore, certain features may sometimes be used to advantage without a corresponding use of other features. Accordingly, Applicants intend to embrace all such alternatives, modifications, equivalents, and variations that are within the spirit and scope of the present invention.
This Application is a U.S. national stage filing under 35 U.S.C. § 371 of International Application No. PCT/US2018/039188, filed Jun. 24, 2018 and published as International Publication Number WO2018237375A1 on Dec. 27, 2018, which claims the benefit of U.S. Provisional Application No. 62/524,492 filed Jun. 24, 2017, each of which are incorporated herein by reference in their entireties.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2018/039188 | 6/24/2018 | WO |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2018/237375 | 12/27/2018 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 2369070 | Nielsen | Feb 1945 | A |
| 2575447 | Gossick | Nov 1951 | A |
| 2874351 | John | Feb 1959 | A |
| 3490591 | Jones et al. | Jan 1970 | A |
| 3526834 | Brown | Sep 1970 | A |
| 3753493 | Mellor | Aug 1973 | A |
| 3786810 | Pannier et al. | Jan 1974 | A |
| 3847809 | Kopf | Nov 1974 | A |
| 3861388 | Vaughn | Jan 1975 | A |
| 3871913 | Shaldon | Mar 1975 | A |
| 3992301 | Shippey et al. | Nov 1976 | A |
| 3994293 | Ferro | Nov 1976 | A |
| 4138639 | Hutchins | Feb 1979 | A |
| 4158034 | Riede et al. | Jun 1979 | A |
| 4161264 | Malmgren et al. | Jul 1979 | A |
| 4197848 | Garrett et al. | Apr 1980 | A |
| 4209391 | Lipps et al. | Jun 1980 | A |
| 4338190 | Kraus et al. | Jul 1982 | A |
| 4361485 | Boonstra | Nov 1982 | A |
| 4396382 | Goldhaber | Aug 1983 | A |
| 4399030 | Hlavinka et al. | Aug 1983 | A |
| 4412834 | Kulin et al. | Nov 1983 | A |
| 4420752 | Davis et al. | Dec 1983 | A |
| 4432759 | Gross et al. | Feb 1984 | A |
| 4432765 | Oscarsson | Feb 1984 | A |
| 4435171 | Goldberg et al. | Mar 1984 | A |
| 4439179 | Lueders et al. | Mar 1984 | A |
| 4439188 | Dennehey et al. | Mar 1984 | A |
| 4440207 | Genatempo et al. | Apr 1984 | A |
| 4447230 | Gula et al. | May 1984 | A |
| 4479760 | Bilstad et al. | Oct 1984 | A |
| 4489535 | Veltman | Dec 1984 | A |
| 4493705 | Gordon et al. | Jan 1985 | A |
| 4526572 | Donnan et al. | Jul 1985 | A |
| 4553552 | Valdespino et al. | Nov 1985 | A |
| 4559043 | Whitehouse et al. | Dec 1985 | A |
| 4585436 | Davis et al. | Apr 1986 | A |
| 4605895 | Park | Aug 1986 | A |
| 4612170 | Luther et al. | Sep 1986 | A |
| 4617115 | Vantard | Oct 1986 | A |
| 4618343 | Polaschegg | Oct 1986 | A |
| 4636204 | Christopherson et al. | Jan 1987 | A |
| 4654026 | Underwood | Mar 1987 | A |
| 4655742 | Vantard | Apr 1987 | A |
| 4657529 | Prince et al. | Apr 1987 | A |
| 4663006 | Yao et al. | May 1987 | A |
| 4670007 | Wheeldon et al. | Jun 1987 | A |
| 4673506 | Henne et al. | Jun 1987 | A |
| 4695385 | Boag | Sep 1987 | A |
| 4702829 | Polaschegg et al. | Oct 1987 | A |
| 4747822 | Peabody | May 1988 | A |
| 4747950 | Guinn | May 1988 | A |
| 4752292 | Lopez et al. | Jun 1988 | A |
| 4797191 | Metzner et al. | Jan 1989 | A |
| 4823833 | Hogan et al. | Apr 1989 | A |
| 4825168 | Ogawa et al. | Apr 1989 | A |
| 4846950 | Yao et al. | Jul 1989 | A |
| 4857199 | Cortial | Aug 1989 | A |
| 4867739 | Kawano | Sep 1989 | A |
| 4871353 | Thomsen | Oct 1989 | A |
| 4876515 | Ball | Oct 1989 | A |
| 4954782 | Ball | Sep 1990 | A |
| 4966585 | Gangemi | Oct 1990 | A |
| 4976685 | Block, Jr. | Dec 1990 | A |
| 4981469 | Whitehouse et al. | Jan 1991 | A |
| 4997570 | Polaschegg | Mar 1991 | A |
| 5004535 | Bosko et al. | Apr 1991 | A |
| 5061365 | Utterberg | Oct 1991 | A |
| 5062774 | Kramer et al. | Nov 1991 | A |
| 5071413 | Utterberg | Dec 1991 | A |
| 5078699 | Haber et al. | Jan 1992 | A |
| 5087245 | Doan | Feb 1992 | A |
| 5139483 | Ryan | Aug 1992 | A |
| 5139675 | Arnold et al. | Aug 1992 | A |
| 5141493 | Jacobsen et al. | Aug 1992 | A |
| 5203771 | Melker et al. | Apr 1993 | A |
| 5209800 | Spencer | May 1993 | A |
| 5224932 | Lappas | Jul 1993 | A |
| 5225783 | Suzuki et al. | Jul 1993 | A |
| 5242392 | Vaughn | Sep 1993 | A |
| 5256371 | Pippert | Oct 1993 | A |
| 5268144 | Heilmann et al. | Dec 1993 | A |
| 5326476 | Grogan et al. | Jul 1994 | A |
| 5330425 | Utterberg | Jul 1994 | A |
| 5336173 | Folden | Aug 1994 | A |
| 5344392 | Senninger et al. | Sep 1994 | A |
| 5344568 | Kitaevich et al. | Sep 1994 | A |
| 5346472 | Keshaviah et al. | Sep 1994 | A |
| 5360395 | Utterberg | Nov 1994 | A |
| 5442969 | Troutner et al. | Aug 1995 | A |
| 5484397 | Twardowski | Jan 1996 | A |
| 5485083 | Pulice | Jan 1996 | A |
| 5486286 | Peterson et al. | Jan 1996 | A |
| 5490925 | Eigendorf | Feb 1996 | A |
| 5522998 | Polaschegg | Jun 1996 | A |
| 5567320 | Goux et al. | Oct 1996 | A |
| 5570026 | Buffaloe, IV et al. | Oct 1996 | A |
| 5589070 | Maltais et al. | Dec 1996 | A |
| 5591344 | Kenley et al. | Jan 1997 | A |
| 5603902 | Maltais et al. | Feb 1997 | A |
| 5628908 | Kamen et al. | May 1997 | A |
| 5631552 | Ogawa et al. | May 1997 | A |
| 5650071 | Brugger et al. | Jul 1997 | A |
| 5651893 | Kenley et al. | Jul 1997 | A |
| 5674390 | Matthews et al. | Oct 1997 | A |
| 5725773 | Polaschegg | Mar 1998 | A |
| 5800383 | Chandler et al. | Sep 1998 | A |
| 5836933 | Buttitta et al. | Nov 1998 | A |
| 5865764 | Moorhead | Feb 1999 | A |
| 5895578 | Simard et al. | Apr 1999 | A |
| 5900136 | Gotsu et al. | May 1999 | A |
| 5925011 | Faict et al. | Jul 1999 | A |
| 5932110 | Shah et al. | Aug 1999 | A |
| 5938634 | Packard | Aug 1999 | A |
| 5945449 | Purcell et al. | Aug 1999 | A |
| 6036680 | Horne et al. | Mar 2000 | A |
| 6110384 | Goux et al. | Aug 2000 | A |
| 6129699 | Haight et al. | Oct 2000 | A |
| 6136201 | Shah et al. | Oct 2000 | A |
| 6139754 | Hartranft et al. | Oct 2000 | A |
| 6156797 | Kubo et al. | Dec 2000 | A |
| 6168578 | Diamond | Jan 2001 | B1 |
| 6196991 | Keilman | Mar 2001 | B1 |
| 6228047 | Dadson | May 2001 | B1 |
| 6241943 | Wieslander et al. | Jun 2001 | B1 |
| 6254567 | Treu et al. | Jul 2001 | B1 |
| 6270673 | Belt et al. | Aug 2001 | B1 |
| 6280634 | Shah et al. | Aug 2001 | B1 |
| 6327895 | Jeppsson et al. | Dec 2001 | B1 |
| 6391404 | Rosenbaum et al. | May 2002 | B1 |
| 6409699 | Ash | Jun 2002 | B1 |
| 6423029 | Elsberry | Jul 2002 | B1 |
| 6460592 | Sano et al. | Oct 2002 | B1 |
| 6463979 | Sano et al. | Oct 2002 | B1 |
| 6471855 | Odak et al. | Oct 2002 | B1 |
| 6488647 | Miura et al. | Dec 2002 | B1 |
| 6489785 | McAllister | Dec 2002 | B2 |
| 6491658 | Miura et al. | Dec 2002 | B1 |
| 6492336 | Mahiout | Dec 2002 | B1 |
| 6503062 | Gray et al. | Jan 2003 | B1 |
| 6537976 | Gupta | Mar 2003 | B1 |
| 6585682 | Haraldsson et al. | Jul 2003 | B1 |
| 6591126 | Roeper et al. | Jul 2003 | B2 |
| 6595948 | Suzuki et al. | Jul 2003 | B2 |
| 6605214 | Taylor | Aug 2003 | B1 |
| 6610206 | Callan et al. | Aug 2003 | B1 |
| 6626862 | Duchon et al. | Sep 2003 | B1 |
| 6645191 | Knerr et al. | Nov 2003 | B1 |
| 6648906 | Lasheras et al. | Nov 2003 | B2 |
| 6666842 | Sakai | Dec 2003 | B1 |
| 6689275 | Gupta | Feb 2004 | B1 |
| 6705372 | Sano et al. | Mar 2004 | B2 |
| 6738052 | Manke et al. | May 2004 | B1 |
| 6749580 | Work et al. | Jun 2004 | B2 |
| 6758975 | Peabody et al. | Jul 2004 | B2 |
| 6769231 | Danby | Aug 2004 | B2 |
| 6803363 | Polaschegg | Oct 2004 | B2 |
| 6808369 | Gray et al. | Oct 2004 | B2 |
| 6814869 | Brandl et al. | Nov 2004 | B2 |
| 6861033 | Mullins et al. | Mar 2005 | B2 |
| 6877713 | Gray et al. | Apr 2005 | B1 |
| 6887214 | Levin | May 2005 | B1 |
| 6889713 | Navis | May 2005 | B2 |
| 6911014 | Wentling et al. | Jun 2005 | B2 |
| 6912917 | Brugger et al. | Jul 2005 | B2 |
| 6929751 | Bowman et al. | Aug 2005 | B2 |
| 6981977 | Herweck et al. | Jan 2006 | B2 |
| 6986752 | McGuckin et al. | Jan 2006 | B2 |
| 6995563 | Talutis | Feb 2006 | B2 |
| 7013928 | Navis | Mar 2006 | B2 |
| 7033539 | Krensky et al. | Apr 2006 | B2 |
| 7053059 | Zieske et al. | May 2006 | B2 |
| 7057400 | Gaignet | Jun 2006 | B2 |
| 7067061 | Bosetto et al. | Jun 2006 | B2 |
| 7083719 | Bowman et al. | Aug 2006 | B2 |
| 7119305 | Sano et al. | Oct 2006 | B2 |
| 7138088 | Wariar et al. | Nov 2006 | B2 |
| 7175606 | Bowman, Jr. et al. | Feb 2007 | B2 |
| 7214228 | Crabtree | May 2007 | B2 |
| 7235589 | Hausheer | Jun 2007 | B2 |
| 7243893 | Sobue et al. | Jul 2007 | B2 |
| 7250619 | Taylor et al. | Jul 2007 | B2 |
| 7320676 | Miesel | Jan 2008 | B2 |
| 7354190 | Demers et al. | Apr 2008 | B2 |
| 7410475 | Krensky et al. | Aug 2008 | B2 |
| 7421316 | Gray et al. | Sep 2008 | B2 |
| 7441108 | Fisher et al. | Oct 2008 | B2 |
| 7459054 | Landherr et al. | Dec 2008 | B2 |
| 7544301 | Shah et al. | Jun 2009 | B2 |
| 7559483 | Hickle et al. | Jul 2009 | B2 |
| 7559524 | Gray et al. | Jul 2009 | B2 |
| 7559913 | Jeppsson et al. | Jul 2009 | B1 |
| 7641753 | Gao et al. | Jan 2010 | B2 |
| 7670491 | Callan et al. | Mar 2010 | B2 |
| 7686279 | Nerbonne et al. | Mar 2010 | B2 |
| 7758552 | Zoltan et al. | Jul 2010 | B2 |
| 7763013 | Baldwin et al. | Jul 2010 | B2 |
| 7803628 | Glocker | Sep 2010 | B2 |
| 7837666 | Jensen et al. | Nov 2010 | B2 |
| 7842002 | Mantle | Nov 2010 | B2 |
| 7847564 | Rossi | Dec 2010 | B2 |
| 7857805 | Raines | Dec 2010 | B2 |
| 7862530 | Callan et al. | Jan 2011 | B2 |
| 7867214 | Childers et al. | Jan 2011 | B2 |
| 7883725 | Shah et al. | Feb 2011 | B2 |
| 7892423 | Rohde et al. | Feb 2011 | B2 |
| 7901376 | Steck et al. | Mar 2011 | B2 |
| 7905853 | Chapman et al. | Mar 2011 | B2 |
| 7905855 | Childers | Mar 2011 | B2 |
| 7935074 | Plahey et al. | May 2011 | B2 |
| 7955295 | Lee et al. | Jun 2011 | B2 |
| 7988849 | Biewer et al. | Aug 2011 | B2 |
| 7993050 | Demers et al. | Aug 2011 | B2 |
| 8034017 | Petersen | Oct 2011 | B2 |
| 8083709 | Childers et al. | Dec 2011 | B2 |
| 8088094 | Hamada et al. | Jan 2012 | B2 |
| 8096969 | Roberts et al. | Jan 2012 | B2 |
| 8105487 | Fulkerson et al. | Jan 2012 | B2 |
| 8147696 | Pandya | Apr 2012 | B1 |
| 8178040 | Brauer | May 2012 | B2 |
| 8202547 | Shah et al. | Jun 2012 | B2 |
| 8222229 | Kiribayashi et al. | Jul 2012 | B2 |
| 8246826 | Wilt et al. | Aug 2012 | B2 |
| 8287724 | Slepicka et al. | Oct 2012 | B2 |
| 8297954 | Moubayed | Oct 2012 | B2 |
| 8298167 | Peters et al. | Oct 2012 | B2 |
| 8298170 | Lundtveit et al. | Oct 2012 | B2 |
| 8308128 | Mackal | Nov 2012 | B2 |
| 8348904 | Petersen | Jan 2013 | B2 |
| 8361009 | Lee et al. | Jan 2013 | B2 |
| 8367731 | Wieslander et al. | Feb 2013 | B2 |
| 8375797 | Beden et al. | Feb 2013 | B2 |
| 8382447 | Wang et al. | Feb 2013 | B2 |
| 8393690 | Grant et al. | Mar 2013 | B2 |
| 8398590 | Sternberg et al. | Mar 2013 | B2 |
| 8414686 | Gura et al. | Apr 2013 | B2 |
| 8414768 | Shah et al. | Apr 2013 | B2 |
| 8431086 | Lurvey et al. | Apr 2013 | B2 |
| 8444593 | Hamada et al. | May 2013 | B2 |
| 8449496 | Tamada et al. | May 2013 | B2 |
| 8460544 | Völker | Jun 2013 | B2 |
| 8474784 | Kashmirian et al. | Jul 2013 | B2 |
| 8491184 | Kamen et al. | Jul 2013 | B2 |
| 8500676 | Jansson et al. | Aug 2013 | B2 |
| 8501009 | Peterson et al. | Aug 2013 | B2 |
| 8516902 | Beavis et al. | Aug 2013 | B2 |
| 8529496 | Britton et al. | Sep 2013 | B2 |
| 8540886 | Hedmann et al. | Sep 2013 | B2 |
| 8556225 | Gray | Oct 2013 | B2 |
| 8560510 | Brueggerhoff et al. | Oct 2013 | B2 |
| 8587516 | Kopychev et al. | Nov 2013 | B2 |
| 8597229 | Pan | Dec 2013 | B2 |
| 8600772 | Bacon | Dec 2013 | B2 |
| 8613739 | Sobue | Dec 2013 | B2 |
| 8641685 | Mansour et al. | Feb 2014 | B2 |
| 8671996 | Weilhoefer et al. | Mar 2014 | B2 |
| 8678224 | D'Ayot et al. | Mar 2014 | B2 |
| 8685251 | Smejtek et al. | Apr 2014 | B2 |
| 8698741 | Wang et al. | Apr 2014 | B1 |
| 8708992 | Kobayashi et al. | Apr 2014 | B2 |
| 8728056 | Colantonio et al. | May 2014 | B2 |
| 8731726 | Gray et al. | May 2014 | B2 |
| 8740864 | Hoang et al. | Jun 2014 | B2 |
| 8741131 | Bedingfield et al. | Jun 2014 | B2 |
| 8747370 | Feith et al. | Jun 2014 | B2 |
| 8758626 | Wong | Jun 2014 | B2 |
| 8764702 | Childers et al. | Jul 2014 | B2 |
| 8774885 | Abreu | Jul 2014 | B2 |
| 8777892 | Sandford et al. | Jul 2014 | B2 |
| 8789558 | Volker | Jul 2014 | B2 |
| 8801652 | Landherr et al. | Aug 2014 | B2 |
| 8801677 | Wallin | Aug 2014 | B2 |
| 8808595 | Babrowicz et al. | Aug 2014 | B2 |
| 8813769 | Gastauer et al. | Aug 2014 | B2 |
| 8815095 | Micheli | Aug 2014 | B2 |
| 8828232 | Shah et al. | Sep 2014 | B2 |
| 8834718 | Randall et al. | Sep 2014 | B2 |
| 8834719 | Childers et al. | Sep 2014 | B2 |
| 8838395 | Matsiev et al. | Sep 2014 | B2 |
| 8840581 | McGill et al. | Sep 2014 | B2 |
| 8858792 | Ding et al. | Oct 2014 | B2 |
| 8869612 | Chen et al. | Oct 2014 | B2 |
| 8870812 | Alberti et al. | Oct 2014 | B2 |
| 8875748 | Beden et al. | Nov 2014 | B2 |
| 8876753 | Roberts et al. | Nov 2014 | B2 |
| 8882700 | Chapman et al. | Nov 2014 | B2 |
| 8924458 | Levin et al. | Dec 2014 | B2 |
| 8926550 | Plahey et al. | Jan 2015 | B2 |
| 8926551 | Lo et al. | Jan 2015 | B2 |
| 8930213 | Gotlib et al. | Jan 2015 | B2 |
| 8945042 | Lee et al. | Feb 2015 | B2 |
| 8961444 | Chapman et al. | Feb 2015 | B2 |
| 8961466 | Steinbach | Feb 2015 | B2 |
| 8980070 | Nishio et al. | Mar 2015 | B2 |
| 8989906 | Gray et al. | Mar 2015 | B2 |
| 8992454 | Anand | Mar 2015 | B2 |
| 8992777 | Doyle | Mar 2015 | B2 |
| 9004886 | Beck et al. | Apr 2015 | B2 |
| 9014775 | Bennett et al. | Apr 2015 | B2 |
| 9022969 | Helmore et al. | May 2015 | B2 |
| 9044544 | Lo et al. | Jun 2015 | B2 |
| 9060727 | Saikley et al. | Jun 2015 | B2 |
| 9066968 | Ohta et al. | Jun 2015 | B2 |
| 9067017 | Tan et al. | Jun 2015 | B2 |
| 9069886 | Shimizu et al. | Jun 2015 | B2 |
| 9108031 | Brandenburger et al. | Aug 2015 | B2 |
| 9112245 | Yen | Aug 2015 | B2 |
| 9132220 | Kugelmann et al. | Sep 2015 | B2 |
| 9138523 | Burnett et al. | Sep 2015 | B2 |
| 9152918 | McNair | Oct 2015 | B1 |
| 9153002 | Jones et al. | Oct 2015 | B2 |
| 9162044 | Traversaz | Oct 2015 | B2 |
| 9165112 | Doyle et al. | Oct 2015 | B2 |
| 9180238 | Bedingfield et al. | Nov 2015 | B2 |
| 9198830 | Kugelmann et al. | Dec 2015 | B2 |
| 9199070 | Wegener et al. | Dec 2015 | B2 |
| 9216247 | Callan et al. | Dec 2015 | B2 |
| 9217702 | Sullivan | Dec 2015 | B2 |
| 9242035 | Karoor | Jan 2016 | B2 |
| 9254356 | Shah et al. | Feb 2016 | B2 |
| 9254358 | Volker | Feb 2016 | B2 |
| 9274073 | Nier et al. | Mar 2016 | B2 |
| 9284960 | Chappel et al. | Mar 2016 | B2 |
| 9308309 | Hedmann et al. | Apr 2016 | B2 |
| 9310232 | Heide et al. | Apr 2016 | B2 |
| 9319110 | Kopychev et al. | Apr 2016 | B2 |
| 9320680 | Schröder | Apr 2016 | B2 |
| 9345871 | Guala | May 2016 | B2 |
| 9358332 | McGill et al. | Jun 2016 | B2 |
| 9381290 | Yu et al. | Jul 2016 | B2 |
| 9393356 | Karoor et al. | Jul 2016 | B2 |
| 9408958 | Wang et al. | Aug 2016 | B2 |
| 9427518 | Brueckner | Aug 2016 | B2 |
| 9433768 | Tekeste et al. | Sep 2016 | B2 |
| 9440016 | Lin et al. | Sep 2016 | B2 |
| 9440019 | Falkenhagen et al. | Sep 2016 | B2 |
| 9470220 | Becker | Oct 2016 | B2 |
| 9471754 | Mastalli et al. | Oct 2016 | B2 |
| 9474841 | Volker | Oct 2016 | B2 |
| 9495511 | Harrington et al. | Nov 2016 | B2 |
| 9500188 | Ly et al. | Nov 2016 | B2 |
| 9514131 | Bochenko et al. | Dec 2016 | B1 |
| 9519969 | Kusens | Dec 2016 | B1 |
| 9539387 | Fini et al. | Jan 2017 | B2 |
| 9555232 | Davis et al. | Jan 2017 | B2 |
| 9593679 | Gray et al. | Mar 2017 | B2 |
| 9610518 | Kamen et al. | Apr 2017 | B2 |
| 9616163 | Wong et al. | Apr 2017 | B2 |
| 9629993 | Klewinghaus | Apr 2017 | B2 |
| 9651511 | Howell et al. | May 2017 | B2 |
| 9669145 | Günther et al. | Jun 2017 | B2 |
| 9677555 | Kamen et al. | Jun 2017 | B2 |
| 9687646 | Sobue et al. | Jun 2017 | B2 |
| 9694125 | Plahey et al. | Jul 2017 | B2 |
| 9694126 | Hedmann et al. | Jul 2017 | B2 |
| 9700711 | Grant et al. | Jul 2017 | B2 |
| 9724270 | Bonnal et al. | Aug 2017 | B2 |
| 9724298 | Nilsson et al. | Aug 2017 | B2 |
| 9724505 | Williams et al. | Aug 2017 | B2 |
| 10973968 | Rohde | Apr 2021 | B2 |
| 20010005487 | Kamibayashi et al. | Jun 2001 | A1 |
| 20020045851 | Suzuki et al. | Apr 2002 | A1 |
| 20020072718 | Brugger et al. | Jun 2002 | A1 |
| 20020087126 | Quah | Jul 2002 | A1 |
| 20020120227 | Childers et al. | Aug 2002 | A1 |
| 20020123715 | Sorenson et al. | Sep 2002 | A1 |
| 20020162778 | Peabody et al. | Nov 2002 | A1 |
| 20030065284 | Briggs | Apr 2003 | A1 |
| 20030086794 | Gray et al. | May 2003 | A1 |
| 20030143352 | Yang et al. | Jul 2003 | A1 |
| 20030153865 | Connell et al. | Aug 2003 | A1 |
| 20030217976 | Bowman et al. | Nov 2003 | A1 |
| 20030218623 | Krensky et al. | Nov 2003 | A1 |
| 20040019312 | Childers et al. | Jan 2004 | A1 |
| 20040031756 | Suzuki et al. | Feb 2004 | A1 |
| 20040040620 | Brauer et al. | Mar 2004 | A1 |
| 20040078024 | Peluso et al. | Apr 2004 | A1 |
| 20040087890 | Sakai | May 2004 | A1 |
| 20040099521 | Demers et al. | May 2004 | A1 |
| 20040108223 | Jansson | Jun 2004 | A1 |
| 20040111294 | McNally et al. | Jun 2004 | A1 |
| 20040215129 | Edgson et al. | Oct 2004 | A1 |
| 20040215336 | Udipi et al. | Oct 2004 | A1 |
| 20040221643 | Ehwald et al. | Nov 2004 | A1 |
| 20040254513 | Shang et al. | Dec 2004 | A1 |
| 20050006296 | Sullivan et al. | Jan 2005 | A1 |
| 20050020507 | Zieske et al. | Jan 2005 | A1 |
| 20050082226 | Bene et al. | Apr 2005 | A1 |
| 20050089994 | Neftel | Apr 2005 | A1 |
| 20050094483 | Demers et al. | May 2005 | A1 |
| 20050094485 | Demers et al. | May 2005 | A1 |
| 20050095154 | Tracey et al. | May 2005 | A1 |
| 20050126998 | Childers | Jun 2005 | A1 |
| 20050131141 | Poss et al. | Jun 2005 | A1 |
| 20050167363 | Taylor | Aug 2005 | A1 |
| 20050173344 | Bowman et al. | Aug 2005 | A1 |
| 20050202395 | Edrich et al. | Sep 2005 | A1 |
| 20050209563 | Hopping et al. | Sep 2005 | A1 |
| 20050211373 | Tomasetti et al. | Sep 2005 | A1 |
| 20050224372 | Sasso et al. | Oct 2005 | A1 |
| 20050244909 | Hamada et al. | Nov 2005 | A1 |
| 20050283132 | Stanus et al. | Dec 2005 | A1 |
| 20060005886 | Parrino et al. | Jan 2006 | A1 |
| 20060015015 | Kawamoto et al. | Jan 2006 | A1 |
| 20060161107 | Mantle | Jul 2006 | A1 |
| 20060172954 | Jensen et al. | Aug 2006 | A1 |
| 20060189923 | Neftel et al. | Aug 2006 | A1 |
| 20060195064 | Plahey et al. | Aug 2006 | A1 |
| 20070007208 | Brugger et al. | Jan 2007 | A1 |
| 20070043317 | Sugawara | Feb 2007 | A1 |
| 20070048161 | Moubayed | Mar 2007 | A1 |
| 20070088314 | Gollier et al. | Apr 2007 | A1 |
| 20070106197 | Lauman et al. | May 2007 | A1 |
| 20070106247 | Burnett et al. | May 2007 | A1 |
| 20070112297 | Plahey et al. | May 2007 | A1 |
| 20070149913 | Busby et al. | Jun 2007 | A1 |
| 20070179422 | Schnell et al. | Aug 2007 | A1 |
| 20070194792 | Quackenbush et al. | Aug 2007 | A1 |
| 20070213651 | Busby et al. | Sep 2007 | A1 |
| 20070213654 | Lundtveit et al. | Sep 2007 | A1 |
| 20070213665 | Curtin et al. | Sep 2007 | A1 |
| 20070253463 | Perry et al. | Nov 2007 | A1 |
| 20070276328 | Childers et al. | Nov 2007 | A1 |
| 20070287966 | Keeley | Dec 2007 | A1 |
| 20080015492 | Biesel | Jan 2008 | A1 |
| 20080023135 | Ivansons et al. | Jan 2008 | A1 |
| 20080027374 | Jensen et al. | Jan 2008 | A1 |
| 20080031746 | Gray et al. | Feb 2008 | A9 |
| 20080058712 | Plahey | Mar 2008 | A1 |
| 20080065006 | Roger et al. | Mar 2008 | A1 |
| 20080097283 | Plahey | Apr 2008 | A1 |
| 20080101969 | Moubayed | May 2008 | A1 |
| 20080112258 | Demers et al. | May 2008 | A1 |
| 20080125693 | Gavin et al. | May 2008 | A1 |
| 20080138223 | Lanigan et al. | Jun 2008 | A1 |
| 20080161751 | Plahey et al. | Jul 2008 | A1 |
| 20080183126 | Landherr et al. | Jul 2008 | A1 |
| 20080183127 | Landherr et al. | Jul 2008 | A1 |
| 20080200865 | Bedingfield | Aug 2008 | A1 |
| 20080200866 | Prisco et al. | Aug 2008 | A1 |
| 20080200867 | Bedingfield | Aug 2008 | A1 |
| 20080200868 | Alberti et al. | Aug 2008 | A1 |
| 20080200869 | Bedingfield | Aug 2008 | A1 |
| 20080208195 | Shores et al. | Aug 2008 | A1 |
| 20080216898 | Grant et al. | Sep 2008 | A1 |
| 20080230450 | Burbank | Sep 2008 | A1 |
| 20080240929 | Kamen et al. | Oct 2008 | A1 |
| 20080243211 | Cartwright et al. | Oct 2008 | A1 |
| 20080253427 | Kamen et al. | Oct 2008 | A1 |
| 20080253911 | Demers et al. | Oct 2008 | A1 |
| 20080273996 | Gray et al. | Nov 2008 | A1 |
| 20080275382 | Biesel et al. | Nov 2008 | A1 |
| 20090007642 | Busby et al. | Jan 2009 | A1 |
| 20090008306 | Cicchello et al. | Jan 2009 | A1 |
| 20090009290 | Kneip et al. | Jan 2009 | A1 |
| 20090012447 | Huitt et al. | Jan 2009 | A1 |
| 20090012451 | Sobue et al. | Jan 2009 | A1 |
| 20090012452 | Slepicka et al. | Jan 2009 | A1 |
| 20090012453 | Childers et al. | Jan 2009 | A1 |
| 20090012455 | Childers et al. | Jan 2009 | A1 |
| 20090012458 | Childers et al. | Jan 2009 | A1 |
| 20090012460 | Steck et al. | Jan 2009 | A1 |
| 20090012464 | Martin et al. | Jan 2009 | A1 |
| 20090024096 | Hai et al. | Jan 2009 | A1 |
| 20090054873 | Landherr et al. | Feb 2009 | A1 |
| 20090078592 | Jensen et al. | Mar 2009 | A1 |
| 20090082758 | Gill et al. | Mar 2009 | A1 |
| 20090095679 | Demers et al. | Apr 2009 | A1 |
| 20090098215 | Riser et al. | Apr 2009 | A1 |
| 20090101549 | Kamen et al. | Apr 2009 | A1 |
| 20090112151 | Chapman et al. | Apr 2009 | A1 |
| 20090143723 | Szpara et al. | Jun 2009 | A1 |
| 20090149810 | Ring et al. | Jun 2009 | A1 |
| 20090169872 | Krongauz et al. | Jul 2009 | A1 |
| 20090173682 | Robinson | Jul 2009 | A1 |
| 20090177149 | Childers et al. | Jul 2009 | A1 |
| 20090182263 | Burbank et al. | Jul 2009 | A1 |
| 20090185920 | Lanigan et al. | Jul 2009 | A1 |
| 20090196776 | Moubayed | Aug 2009 | A1 |
| 20090198170 | Childers et al. | Aug 2009 | A1 |
| 20090206023 | Rohde et al. | Aug 2009 | A1 |
| 20090212178 | Westberg | Aug 2009 | A1 |
| 20090213521 | Bedingfield | Aug 2009 | A1 |
| 20090218290 | Poss et al. | Sep 2009 | A1 |
| 20090222119 | Plahey et al. | Sep 2009 | A1 |
| 20090223899 | Poss et al. | Sep 2009 | A1 |
| 20090232908 | Zhou | Sep 2009 | A1 |
| 20090264854 | Jensen et al. | Oct 2009 | A1 |
| 20090275881 | Lo et al. | Nov 2009 | A1 |
| 20090275883 | Chapman et al. | Nov 2009 | A1 |
| 20090277276 | Evering et al. | Nov 2009 | A1 |
| 20090294339 | Biewer et al. | Dec 2009 | A1 |
| 20090295591 | Bedingfield | Dec 2009 | A1 |
| 20090299272 | Hopping et al. | Dec 2009 | A1 |
| 20090299273 | Lee et al. | Dec 2009 | A1 |
| 20100004588 | Yeh et al. | Jan 2010 | A1 |
| 20100004589 | Hedmann et al. | Jan 2010 | A1 |
| 20100004590 | Hedmann et al. | Jan 2010 | A1 |
| 20100005416 | Hedmann et al. | Jan 2010 | A1 |
| 20100010423 | Yu et al. | Jan 2010 | A1 |
| 20100010424 | Yu et al. | Jan 2010 | A1 |
| 20100010425 | Yu et al. | Jan 2010 | A1 |
| 20100010426 | Childers et al. | Jan 2010 | A1 |
| 20100010427 | Yu et al. | Jan 2010 | A1 |
| 20100010428 | Yu et al. | Jan 2010 | A1 |
| 20100016802 | Tambourgi et al. | Jan 2010 | A1 |
| 20100019686 | Gutierrez | Jan 2010 | A1 |
| 20100028170 | Schneeberger et al. | Feb 2010 | A1 |
| 20100028208 | Shekalim et al. | Feb 2010 | A1 |
| 20100038322 | Hedmann et al. | Feb 2010 | A1 |
| 20100049158 | Roger | Feb 2010 | A1 |
| 20100051552 | Rohde et al. | Mar 2010 | A1 |
| 20100063445 | Sternberg et al. | Mar 2010 | A1 |
| 20100069817 | Falkvall | Mar 2010 | A1 |
| 20100078387 | Wong | Apr 2010 | A1 |
| 20100084326 | Takesawa | Apr 2010 | A1 |
| 20100087777 | Hopping et al. | Apr 2010 | A1 |
| 20100096329 | Kotanko et al. | Apr 2010 | A1 |
| 20100100027 | Schilthuizen et al. | Apr 2010 | A1 |
| 20100100034 | Wich-Heiter | Apr 2010 | A1 |
| 20100114012 | Sandford et al. | May 2010 | A1 |
| 20100129247 | Lauer | May 2010 | A1 |
| 20100130918 | Elahi | May 2010 | A1 |
| 20100130919 | Elahi | May 2010 | A1 |
| 20100133153 | Beden et al. | Jun 2010 | A1 |
| 20100137782 | Jansson et al. | Jun 2010 | A1 |
| 20100168652 | Andherr et al. | Jul 2010 | A1 |
| 20100169513 | Levin | Jul 2010 | A1 |
| 20100185132 | Han et al. | Jul 2010 | A1 |
| 20100187476 | Yugari et al. | Jul 2010 | A1 |
| 20100191180 | Childers et al. | Jul 2010 | A1 |
| 20100191181 | Childers et al. | Jul 2010 | A1 |
| 20100192686 | Kamen et al. | Aug 2010 | A1 |
| 20100197817 | Bui et al. | Aug 2010 | A1 |
| 20100204765 | Hall et al. | Aug 2010 | A1 |
| 20100217178 | Lo et al. | Aug 2010 | A1 |
| 20100217179 | Lo et al. | Aug 2010 | A1 |
| 20100217180 | Akonur et al. | Aug 2010 | A1 |
| 20100222735 | Plahey et al. | Sep 2010 | A1 |
| 20100224492 | Ding et al. | Sep 2010 | A1 |
| 20100229978 | Zhou | Sep 2010 | A1 |
| 20100241062 | Morris et al. | Sep 2010 | A1 |
| 20100252490 | Fulkerson et al. | Oct 2010 | A1 |
| 20100252702 | Spang et al. | Oct 2010 | A1 |
| 20100258690 | Kleitsch et al. | Oct 2010 | A1 |
| 20100296953 | Gray | Nov 2010 | A1 |
| 20100308243 | Bedingfield | Dec 2010 | A1 |
| 20100312174 | Hoffman | Dec 2010 | A1 |
| 20100314314 | Ding et al. | Dec 2010 | A1 |
| 20100326916 | Wrazel et al. | Dec 2010 | A1 |
| 20100331768 | Hedmann et al. | Dec 2010 | A1 |
| 20110000902 | Hedmann et al. | Jan 2011 | A1 |
| 20110004152 | Brady et al. | Jan 2011 | A1 |
| 20110010101 | Lo et al. | Jan 2011 | A1 |
| 20110015610 | Plahey et al. | Jan 2011 | A1 |
| 20110017665 | Updyke et al. | Jan 2011 | A1 |
| 20110034866 | Zhang et al. | Feb 2011 | A1 |
| 20110038755 | Pesci et al. | Feb 2011 | A1 |
| 20110040242 | Fallon et al. | Feb 2011 | A1 |
| 20110040243 | Busby et al. | Feb 2011 | A1 |
| 20110040244 | Busby et al. | Feb 2011 | A1 |
| 20110046533 | Stefani et al. | Feb 2011 | A1 |
| 20110054397 | Schneeberger | Mar 2011 | A1 |
| 20110064608 | Lee et al. | Mar 2011 | A1 |
| 20110085923 | Gray et al. | Apr 2011 | A1 |
| 20110092893 | Demers et al. | Apr 2011 | A1 |
| 20110092895 | Yardimci et al. | Apr 2011 | A1 |
| 20110093294 | Elahi et al. | Apr 2011 | A1 |
| 20110098635 | Helmore et al. | Apr 2011 | A1 |
| 20110105979 | Schlaeper et al. | May 2011 | A1 |
| 20110105981 | Wagner et al. | May 2011 | A1 |
| 20110114559 | Fislage et al. | May 2011 | A1 |
| 20110131058 | McNally et al. | Jun 2011 | A1 |
| 20110132838 | Curtis et al. | Jun 2011 | A1 |
| 20110137236 | Prisco et al. | Jun 2011 | A1 |
| 20110137237 | Prisco et al. | Jun 2011 | A1 |
| 20110138936 | Collins et al. | Jun 2011 | A1 |
| 20110141116 | Dalesch et al. | Jun 2011 | A1 |
| 20110144557 | Childers et al. | Jun 2011 | A1 |
| 20110144569 | Britton et al. | Jun 2011 | A1 |
| 20110158823 | Wang et al. | Jun 2011 | A1 |
| 20110160649 | Pan | Jun 2011 | A1 |
| 20110163033 | Chapman et al. | Jul 2011 | A1 |
| 20110166507 | Childers et al. | Jul 2011 | A1 |
| 20110171713 | Bluchel et al. | Jul 2011 | A1 |
| 20110184339 | Tan | Jul 2011 | A1 |
| 20110184340 | Tan et al. | Jul 2011 | A1 |
| 20110186517 | Hedmann et al. | Aug 2011 | A1 |
| 20110189048 | Curtis et al. | Aug 2011 | A1 |
| 20110190691 | Cazzini | Aug 2011 | A1 |
| 20110192796 | Smejtek et al. | Aug 2011 | A1 |
| 20110196289 | Plahey et al. | Aug 2011 | A1 |
| 20110198350 | Meisberger et al. | Aug 2011 | A1 |
| 20110218486 | Huitt et al. | Sep 2011 | A1 |
| 20110224603 | Richter | Sep 2011 | A1 |
| 20110230822 | Lee et al. | Sep 2011 | A1 |
| 20110249916 | Herrenbauer et al. | Oct 2011 | A1 |
| 20110257124 | Fenn et al. | Oct 2011 | A1 |
| 20110262555 | Riser et al. | Oct 2011 | A1 |
| 20110264042 | Shang et al. | Oct 2011 | A1 |
| 20110266221 | Ware et al. | Nov 2011 | A1 |
| 20110275984 | Biewer et al. | Nov 2011 | A1 |
| 20110284377 | Rohde | Nov 2011 | A1 |
| 20110286167 | Winkler | Nov 2011 | A1 |
| 20110288480 | Bedingfield et al. | Nov 2011 | A1 |
| 20110300231 | Peterson et al. | Dec 2011 | A1 |
| 20110309019 | Ahrens | Dec 2011 | A1 |
| 20120001762 | Turner et al. | Jan 2012 | A1 |
| 20120022440 | Childers et al. | Jan 2012 | A1 |
| 20120029325 | Neftel | Feb 2012 | A1 |
| 20120029937 | Neftel et al. | Feb 2012 | A1 |
| 20120030933 | Lanigan et al. | Feb 2012 | A1 |
| 20120031826 | Childers et al. | Feb 2012 | A1 |
| 20120035533 | Britton et al. | Feb 2012 | A1 |
| 20120058328 | Tourvieille et al. | Mar 2012 | A1 |
| 20120065581 | Childers et al. | Mar 2012 | A1 |
| 20120067805 | Childers et al. | Mar 2012 | A1 |
| 20120071815 | Childers et al. | Mar 2012 | A1 |
| 20120071816 | Busby et al. | Mar 2012 | A1 |
| 20120074060 | Lass | Mar 2012 | A1 |
| 20120078168 | Veneroni et al. | Mar 2012 | A1 |
| 20120082576 | Beck et al. | Apr 2012 | A1 |
| 20120089085 | Childers et al. | Apr 2012 | A1 |
| 20120095392 | Jensen et al. | Apr 2012 | A1 |
| 20120105850 | Slepicka | May 2012 | A1 |
| 20120116294 | Boenig et al. | May 2012 | A1 |
| 20120132574 | Ware et al. | May 2012 | A1 |
| 20120145615 | Rohde et al. | Jun 2012 | A1 |
| 20120150102 | Childers et al. | Jun 2012 | A1 |
| 20120179133 | Bedingfield et al. | Jul 2012 | A1 |
| 20120185267 | Kamen et al. | Jul 2012 | A1 |
| 20120185619 | Levin | Jul 2012 | A1 |
| 20120199205 | Eyrard et al. | Aug 2012 | A1 |
| 20120205306 | Reich et al. | Aug 2012 | A1 |
| 20120209169 | Morris et al. | Aug 2012 | A1 |
| 20120211422 | Thys | Aug 2012 | A1 |
| 20120212434 | Bluemler et al. | Aug 2012 | A1 |
| 20120212455 | Kloeffel | Aug 2012 | A1 |
| 20120215151 | Han et al. | Aug 2012 | A1 |
| 20120215159 | Childers et al. | Aug 2012 | A1 |
| 20120226237 | Russo | Sep 2012 | A1 |
| 20120230844 | Farrell et al. | Sep 2012 | A1 |
| 20120232469 | Medina | Sep 2012 | A1 |
| 20120238525 | Leypoldt et al. | Sep 2012 | A1 |
| 20120241367 | Childers et al. | Sep 2012 | A1 |
| 20120248017 | Beiriger et al. | Oct 2012 | A1 |
| 20120259275 | Jensen et al. | Oct 2012 | A1 |
| 20120265145 | Mefti et al. | Oct 2012 | A1 |
| 20120271226 | Farrell et al. | Oct 2012 | A1 |
| 20120271273 | Childers et al. | Oct 2012 | A1 |
| 20120273354 | Orhan et al. | Nov 2012 | A1 |
| 20120283629 | Childers et al. | Nov 2012 | A1 |
| 20120310150 | Brandl et al. | Dec 2012 | A1 |
| 20120318740 | Ekdahl et al. | Dec 2012 | A1 |
| 20130006171 | Griessmann et al. | Jan 2013 | A1 |
| 20130020237 | Wilt et al. | Jan 2013 | A1 |
| 20130030356 | Ding et al. | Jan 2013 | A1 |
| 20130030404 | Gerlach et al. | Jan 2013 | A1 |
| 20130037142 | Farrell | Feb 2013 | A1 |
| 20130037461 | Biewer et al. | Feb 2013 | A1 |
| 20130037465 | Heyes et al. | Feb 2013 | A1 |
| 20130056419 | Curtis | Mar 2013 | A1 |
| 20130072895 | Kreischer | Mar 2013 | A1 |
| 20130075309 | West et al. | Mar 2013 | A1 |
| 20130079705 | Cazzini | Mar 2013 | A1 |
| 20130079706 | Childers et al. | Mar 2013 | A1 |
| 20130085437 | Deshpande | Apr 2013 | A1 |
| 20130085451 | Sheu | Apr 2013 | A1 |
| 20130106609 | Singh et al. | May 2013 | A1 |
| 20130126430 | Kenley et al. | May 2013 | A1 |
| 20130131581 | Lundtveit et al. | May 2013 | A1 |
| 20130131583 | Chapman et al. | May 2013 | A1 |
| 20130138037 | Lee et al. | May 2013 | A1 |
| 20130150781 | Busby et al. | Jun 2013 | A1 |
| 20130153048 | Schwalm | Jun 2013 | A1 |
| 20130158469 | Hopping et al. | Jun 2013 | A1 |
| 20130165848 | Sebesta et al. | Jun 2013 | A1 |
| 20130167052 | Niesslein et al. | Jun 2013 | A1 |
| 20130172806 | Griessmann et al. | Jul 2013 | A1 |
| 20130177455 | Kamen et al. | Jul 2013 | A1 |
| 20130180905 | Wong | Jul 2013 | A1 |
| 20130186759 | Lin et al. | Jul 2013 | A1 |
| 20130190681 | Jansson et al. | Jul 2013 | A1 |
| 20130193041 | Rohde | Aug 2013 | A1 |
| 20130195792 | Chan et al. | Aug 2013 | A1 |
| 20130204173 | Kelly et al. | Aug 2013 | A1 |
| 20130205873 | Wagner et al. | Aug 2013 | A1 |
| 20130211322 | Degen et al. | Aug 2013 | A1 |
| 20130245530 | Brandl et al. | Sep 2013 | A1 |
| 20130245531 | Brandl et al. | Sep 2013 | A1 |
| 20130248448 | Shah et al. | Sep 2013 | A1 |
| 20130248449 | Kelly et al. | Sep 2013 | A1 |
| 20130263650 | Nier et al. | Oct 2013 | A1 |
| 20130272902 | Chappel | Oct 2013 | A1 |
| 20130277306 | Chapman et al. | Oct 2013 | A1 |
| 20130310726 | Miller et al. | Nov 2013 | A1 |
| 20130310735 | Yu et al. | Nov 2013 | A1 |
| 20130310736 | Hedmann et al. | Nov 2013 | A1 |
| 20130313191 | Wolf et al. | Nov 2013 | A1 |
| 20130317795 | Akonur et al. | Nov 2013 | A1 |
| 20130324915 | (Krensky) Britton et al. | Dec 2013 | A1 |
| 20130330208 | Ly et al. | Dec 2013 | A1 |
| 20130331774 | Farrell et al. | Dec 2013 | A1 |
| 20130331775 | Britton et al. | Dec 2013 | A1 |
| 20130334138 | Cicchello et al. | Dec 2013 | A1 |
| 20130338102 | Martis et al. | Dec 2013 | A1 |
| 20130345621 | Cicchello et al. | Dec 2013 | A1 |
| 20130346099 | Yu et al. | Dec 2013 | A1 |
| 20130346102 | Yu et al. | Dec 2013 | A1 |
| 20140010691 | Lanigan et al. | Jan 2014 | A1 |
| 20140018272 | Thoea et al. | Jan 2014 | A1 |
| 20140018727 | Burbank et al. | Jan 2014 | A1 |
| 20140021115 | Ellegaard | Jan 2014 | A1 |
| 20140027380 | Childers et al. | Jan 2014 | A1 |
| 20140031631 | Hall et al. | Jan 2014 | A1 |
| 20140046150 | Gagel et al. | Feb 2014 | A1 |
| 20140046248 | Fini et al. | Feb 2014 | A1 |
| 20140052044 | Crnkovich et al. | Feb 2014 | A1 |
| 20140074018 | Childers et al. | Mar 2014 | A1 |
| 20140098359 | Gross et al. | Apr 2014 | A1 |
| 20140129250 | Daniel et al. | May 2014 | A1 |
| 20140135878 | Burnett et al. | May 2014 | A1 |
| 20140148409 | Ohta et al. | May 2014 | A1 |
| 20140188040 | Busby et al. | Jul 2014 | A1 |
| 20140207055 | Junod et al. | Jul 2014 | A1 |
| 20140216994 | Ki | Aug 2014 | A1 |
| 20140217029 | Meyer et al. | Aug 2014 | A1 |
| 20140217030 | Meyer et al. | Aug 2014 | A1 |
| 20140249683 | Gray et al. | Sep 2014 | A1 |
| 20140263063 | Jones | Sep 2014 | A1 |
| 20140288947 | Simpson et al. | Sep 2014 | A1 |
| 20140291218 | Bluchel et al. | Oct 2014 | A1 |
| 20140299545 | Wrazel et al. | Oct 2014 | A1 |
| 20140316332 | Lo et al. | Oct 2014 | A1 |
| 20140360594 | Lee et al. | Dec 2014 | A1 |
| 20150005699 | Burbank | Jan 2015 | A1 |
| 20150014249 | Alberti et al. | Jan 2015 | A1 |
| 20150051536 | Mendels et al. | Feb 2015 | A1 |
| 20150088053 | Lundtveit et al. | Mar 2015 | A1 |
| 20150093450 | Riser et al. | Apr 2015 | A1 |
| 20150129055 | Byler | May 2015 | A1 |
| 20150133854 | Zhu et al. | May 2015 | A1 |
| 20150159643 | Koob | Jun 2015 | A1 |
| 20150196698 | Grant et al. | Jul 2015 | A1 |
| 20150197431 | Shiki | Jul 2015 | A1 |
| 20150204807 | Kamen et al. | Jul 2015 | A1 |
| 20150209500 | Lin et al. | Jul 2015 | A1 |
| 20150231571 | Volker | Aug 2015 | A1 |
| 20150233367 | Shimogata et al. | Aug 2015 | A1 |
| 20150273471 | Manzella, Jr. | Oct 2015 | A1 |
| 20150276742 | Henrie | Oct 2015 | A1 |
| 20150335808 | White et al. | Nov 2015 | A1 |
| 20150359956 | Gray et al. | Dec 2015 | A1 |
| 20160030654 | Singh et al. | Feb 2016 | A1 |
| 20160051949 | Jansson et al. | Feb 2016 | A1 |
| 20160097382 | Kamen et al. | Apr 2016 | A1 |
| 20160106904 | Cicchello et al. | Apr 2016 | A1 |
| 20160153444 | Chappel et al. | Jun 2016 | A1 |
| 20160193399 | Wallace et al. | Jul 2016 | A1 |
| 20160206804 | Holmer et al. | Jul 2016 | A1 |
| 20160239637 | Miller et al. | Aug 2016 | A1 |
| 20160245277 | Lanigan et al. | Aug 2016 | A1 |
| 20160271312 | Lance et al. | Sep 2016 | A1 |
| 20160310653 | Wang et al. | Oct 2016 | A1 |
| 20160319954 | Smith | Nov 2016 | A1 |
| 20160346451 | Stonger et al. | Dec 2016 | A1 |
| 20160362234 | Peret et al. | Dec 2016 | A1 |
| 20160367794 | Bedingfield | Dec 2016 | A1 |
| 20170043079 | Jensen et al. | Feb 2017 | A1 |
| 20170112992 | Plahey et al. | Apr 2017 | A1 |
| 20170157310 | Scarpaci et al. | Jun 2017 | A1 |
| 20170157311 | Egley | Jun 2017 | A1 |
| 20170232175 | Burbank et al. | Aug 2017 | A1 |
| 20170281846 | Manda et al. | Oct 2017 | A1 |
| 20170319768 | Szpara et al. | Nov 2017 | A1 |
| 20170319769 | Wieslander et al. | Nov 2017 | A1 |
| 20170319770 | Fitzgerald et al. | Nov 2017 | A1 |
| 20170333609 | O'Brien et al. | Nov 2017 | A1 |
| 20180021501 | Gerber et al. | Jan 2018 | A1 |
| 20180043079 | Gerber et al. | Feb 2018 | A1 |
| 20180066648 | Kamen et al. | Mar 2018 | A1 |
| 20180078692 | Cicchello et al. | Mar 2018 | A1 |
| 20180093031 | Crawford et al. | Apr 2018 | A1 |
| 20180106246 | Kamen et al. | Apr 2018 | A1 |
| 20180128259 | Kamen et al. | May 2018 | A1 |
| Number | Date | Country |
|---|---|---|
| 2544144 | Oct 2012 | CA |
| 2791816 | Dec 2013 | CA |
| 2832661 | Aug 2016 | CA |
| 201150709 | Nov 2008 | CN |
| 201710718 | Jan 2011 | CN |
| 201806987 | Apr 2011 | CN |
| 101901000 | Nov 2011 | CN |
| 102258942 | Nov 2011 | CN |
| 202116617 | Jan 2012 | CN |
| 102363054 | Feb 2012 | CN |
| 202355628 | Aug 2012 | CN |
| 202379834 | Aug 2012 | CN |
| 202478260 | Oct 2012 | CN |
| 202505852 | Oct 2012 | CN |
| 202542986 | Nov 2012 | CN |
| 102989047 | Mar 2013 | CN |
| 202822485 | Mar 2013 | CN |
| 204723486 | Oct 2015 | CN |
| 105013031 | Nov 2015 | CN |
| 204824277 | Dec 2015 | CN |
| 2838414 | Mar 1980 | DE |
| 4308586 | May 1994 | DE |
| 19546027 | Apr 1997 | DE |
| 29918801 | Mar 2000 | DE |
| 69725104 | Jul 2004 | DE |
| 102007020573 | Nov 2008 | DE |
| 102007053752 | May 2009 | DE |
| 102008045422 | Mar 2010 | DE |
| 102009037917 | Feb 2011 | DE |
| 102010009816 | Sep 2011 | DE |
| 102010033241 | Feb 2012 | DE |
| 102010053903 | Jun 2012 | DE |
| 102011103325 | Dec 2012 | DE |
| 102012004673 | Sep 2013 | DE |
| 102012007412 | Oct 2013 | DE |
| 102013103223 | Oct 2014 | DE |
| 102013013414 | Jan 2015 | DE |
| 102013013415 | Feb 2015 | DE |
| 102013016204 | Apr 2015 | DE |
| 102013018444 | May 2015 | DE |
| 102014201714 | Aug 2015 | DE |
| 102014004476 | Oct 2015 | DE |
| 102014013152 | Mar 2016 | DE |
| 102015010418 | Feb 2017 | DE |
| 0049673 | Apr 1982 | EP |
| 100682 | Feb 1984 | EP |
| 0104460 | Apr 1984 | EP |
| 0112104 | Jun 1984 | EP |
| 0256640 | Feb 1988 | EP |
| 0265352 | Apr 1988 | EP |
| 0090093 | Jun 1988 | EP |
| 0367252 | May 1990 | EP |
| 0442310 | Aug 1991 | EP |
| 0611227 | Aug 1994 | EP |
| 0711569 | May 1996 | EP |
| 0763367 | Mar 1997 | EP |
| 0778033 | Jun 1997 | EP |
| 0813880 | Dec 1997 | EP |
| 1187642 | Mar 2002 | EP |
| 1314442 | May 2003 | EP |
| 0846470 | Sep 2003 | EP |
| 1346749 | Sep 2003 | EP |
| 1048316 | Oct 2003 | EP |
| 0971674 | Dec 2003 | EP |
| 0914093 | Feb 2004 | EP |
| 1438981 | Jul 2004 | EP |
| 1438982 | Jul 2004 | EP |
| 0970699 | Sep 2005 | EP |
| 0994739 | Sep 2005 | EP |
| 0958832 | Jan 2006 | EP |
| 1648536 | Apr 2006 | EP |
| 1066068 | Jul 2006 | EP |
| 1677900 | Jul 2006 | EP |
| 1351726 | Feb 2007 | EP |
| 1382359 | Feb 2007 | EP |
| 1110564 | May 2007 | EP |
| 1236685 | Aug 2007 | EP |
| 1867359 | Dec 2007 | EP |
| 1938849 | Jul 2008 | EP |
| 1191960 | Sep 2008 | EP |
| 1582227 | Nov 2008 | EP |
| 1218039 | Feb 2009 | EP |
| 1641473 | Apr 2010 | EP |
| 1357958 | Aug 2010 | EP |
| 2289577 | Mar 2011 | EP |
| 1432462 | May 2011 | EP |
| 2350897 | Aug 2011 | EP |
| 2402047 | Jan 2012 | EP |
| 1509231 | Feb 2012 | EP |
| 1465687 | May 2012 | EP |
| 2446910 | May 2012 | EP |
| 1195171 | Aug 2012 | EP |
| 2503150 | Sep 2012 | EP |
| 2510958 | Oct 2012 | EP |
| 2517742 | Oct 2012 | EP |
| 1735028 | Jul 2013 | EP |
| 2656785 | Oct 2013 | EP |
| 2689790 | Jan 2014 | EP |
| 2712648 | Mar 2015 | EP |
| 2688602 | Oct 2015 | EP |
| 1878430 | Apr 2016 | EP |
| 2114487 | Apr 2016 | EP |
| 2131891 | Apr 2016 | EP |
| 2173433 | May 2016 | EP |
| 3222305 | Sep 2017 | EP |
| 2594340 | Aug 1987 | FR |
| 2021418 | Dec 1979 | GB |
| 2312055 | Jul 2000 | GB |
| S59166156 | Sep 1984 | JP |
| 60155952 | Aug 1985 | JP |
| S61008057 | Jan 1986 | JP |
| H05502614 | May 1993 | JP |
| 2001511400 | Aug 2001 | JP |
| 2002539896 | Nov 2002 | JP |
| 2002355305 | Dec 2002 | JP |
| 2003024435 | Jan 2003 | JP |
| 2003509126 | Mar 2003 | JP |
| 2003205031 | Jul 2003 | JP |
| 2004518462 | Jun 2004 | JP |
| 2006181386 | Jul 2006 | JP |
| 2005533574 | Aug 2006 | JP |
| 2006218037 | Aug 2006 | JP |
| 2008119509 | May 2008 | JP |
| 03150035 | Apr 2009 | JP |
| 2009131573 | Jun 2009 | JP |
| 2009139091 | Jun 2009 | JP |
| 2009142436 | Jul 2009 | JP |
| 2009533092 | Sep 2009 | JP |
| 2009539522 | Nov 2009 | JP |
| 2009279110 | Dec 2009 | JP |
| 2009279532 | Dec 2009 | JP |
| 2010502405 | Jan 2010 | JP |
| 2010042312 | Feb 2010 | JP |
| 2010088759 | Apr 2010 | JP |
| 2010099631 | May 2010 | JP |
| 2010131495 | Jun 2010 | JP |
| 2010175285 | Aug 2010 | JP |
| 2010214132 | Sep 2010 | JP |
| 2010238013 | Oct 2010 | JP |
| 2010532217 | Oct 2010 | JP |
| 2010279423 | Dec 2010 | JP |
| 2011056395 | Mar 2011 | JP |
| 2011067535 | Apr 2011 | JP |
| 2011120713 | Jun 2011 | JP |
| 2011131209 | Jul 2011 | JP |
| 2011188996 | Sep 2011 | JP |
| 2011189190 | Sep 2011 | JP |
| 2011207867 | Oct 2011 | JP |
| 2011217965 | Nov 2011 | JP |
| 2011241174 | Dec 2011 | JP |
| 2012011260 | Jan 2012 | JP |
| 2012071287 | Apr 2012 | JP |
| 2012075572 | Apr 2012 | JP |
| 2012075573 | Apr 2012 | JP |
| 2012075574 | Apr 2012 | JP |
| 2012075575 | Apr 2012 | JP |
| 2012210382 | Nov 2012 | JP |
| 2012223248 | Nov 2012 | JP |
| 2012228285 | Nov 2012 | JP |
| 2013006128 | Jan 2013 | JP |
| 2013048894 | Mar 2013 | JP |
| 2013048895 | Mar 2013 | JP |
| 2013202231 | Oct 2013 | JP |
| 2014014645 | Jan 2014 | JP |
| 2014519345 | Aug 2014 | JP |
| 2014184380 | Oct 2014 | JP |
| 2014184384 | Oct 2014 | JP |
| 2014184410 | Oct 2014 | JP |
| 2014184411 | Oct 2014 | JP |
| 2015517834 | Jun 2015 | JP |
| 2017000802 | Jan 2017 | JP |
| 2017006538 | Jan 2017 | JP |
| 6080937 | Feb 2017 | JP |
| 2018027256 | Feb 2018 | JP |
| 2018050751 | Apr 2018 | JP |
| 20120118906 | Oct 2012 | KR |
| M411244 | Sep 2011 | TW |
| 1983002060 | Jun 1983 | WO |
| 1984000137 | Jan 1984 | WO |
| 1984000340 | Feb 1984 | WO |
| 1992003202 | Mar 1992 | WO |
| 1994020154 | Sep 1994 | WO |
| 1996025214 | Aug 1996 | WO |
| WO-9625214 | Aug 1996 | WO |
| 1997007837 | Mar 1997 | WO |
| 1998032480 | Jul 1998 | WO |
| 1999006082 | Feb 1999 | WO |
| 2000057833 | Oct 2000 | WO |
| 2000057935 | Oct 2000 | WO |
| 0119413 | Mar 2001 | WO |
| 2001032237 | May 2001 | WO |
| 2001058509 | Aug 2001 | WO |
| 0232476 | Apr 2002 | WO |
| 2002066099 | Aug 2002 | WO |
| 2004006992 | Jan 2004 | WO |
| 2004009156 | Jan 2004 | WO |
| 2004043566 | May 2004 | WO |
| 2005009511 | Feb 2005 | WO |
| 2005042139 | May 2005 | WO |
| 2005089832 | Sep 2005 | WO |
| 2007061368 | May 2007 | WO |
| 2007091217 | Aug 2007 | WO |
| 2007103411 | Sep 2007 | WO |
| 2007118235 | Oct 2007 | WO |
| 2007144427 | Dec 2007 | WO |
| 2007148443 | Dec 2007 | WO |
| 2008086619 | Jul 2008 | WO |
| 2008106440 | Sep 2008 | WO |
| 2008154435 | Dec 2008 | WO |
| 2009005900 | Jan 2009 | WO |
| 2009094182 | Jul 2009 | WO |
| 2009094183 | Jul 2009 | WO |
| 2009094186 | Jul 2009 | WO |
| 2009127683 | Oct 2009 | WO |
| 2009134881 | Nov 2009 | WO |
| 2010002830 | Jan 2010 | WO |
| 2010009867 | Jan 2010 | WO |
| 2010020380 | Feb 2010 | WO |
| 2010024963 | Mar 2010 | WO |
| 2010031424 | Mar 2010 | WO |
| 2010059959 | May 2010 | WO |
| 2010121751 | Oct 2010 | WO |
| 2010143693 | Dec 2010 | WO |
| 2011017215 | Feb 2011 | WO |
| 2011052348 | May 2011 | WO |
| 2011065222 | Jun 2011 | WO |
| 2011091998 | Aug 2011 | WO |
| 2011113615 | Sep 2011 | WO |
| 2011132165 | Oct 2011 | WO |
| 2012049261 | Apr 2012 | WO |
| 2012087798 | Jun 2012 | WO |
| 2012095829 | Jul 2012 | WO |
| 2012129501 | Nov 2012 | WO |
| 2012148781 | Nov 2012 | WO |
| 2012163537 | Dec 2012 | WO |
| 2012172818 | Dec 2012 | WO |
| 2012176135 | Dec 2012 | WO |
| 2013000569 | Jan 2013 | WO |
| 2013012744 | Jan 2013 | WO |
| 2013019179 | Feb 2013 | WO |
| 2013019994 | Feb 2013 | WO |
| 2013040420 | Mar 2013 | WO |
| 2013051927 | Apr 2013 | WO |
| 2013057109 | Apr 2013 | WO |
| 2013110919 | Aug 2013 | WO |
| 2013114063 | Aug 2013 | WO |
| 2013121162 | Aug 2013 | WO |
| 2013135386 | Sep 2013 | WO |
| 2013135388 | Sep 2013 | WO |
| 2013141896 | Sep 2013 | WO |
| 2013159935 | Oct 2013 | WO |
| 2013163949 | Nov 2013 | WO |
| 2013185080 | Dec 2013 | WO |
| 2013191344 | Dec 2013 | WO |
| 2014009111 | Jan 2014 | WO |
| 2014053858 | Apr 2014 | WO |
| 2014081367 | May 2014 | WO |
| 2014106010 | Jul 2014 | WO |
| 2014124186 | Aug 2014 | WO |
| 2014155120 | Oct 2014 | WO |
| 2014162489 | Oct 2014 | WO |
| 2015050752 | Apr 2015 | WO |
| 2015177606 | Nov 2015 | WO |
| 2015188154 | Dec 2015 | WO |
| WO-2016049542 | Mar 2016 | WO |
| 2016059634 | Apr 2016 | WO |
| 2016080883 | May 2016 | WO |
| 2016088072 | Jun 2016 | WO |
| 2016091366 | Jun 2016 | WO |
| 2016095026 | Jun 2016 | WO |
| 2016193930 | Dec 2016 | WO |
| 2016206949 | Dec 2016 | WO |
| 2017193065 | Nov 2017 | WO |
| 2018041760 | Mar 2018 | WO |
| 2018115028 | Jun 2018 | WO |
| Entry |
|---|
| Communication under Rule 71(3) EPC dated Apr. 23, 2020, issued in EP 19 166 992.8. |
| Office Action (Communication Pursuant to Article 94(3) EPC) dated Jun. 24, 2020 for European Patent Application No. 19173274.2. |
| English language abstract for Swedish application publication No. SE 198300739 A, published Aug. 13, 1983. |
| Examination Report for United Kingdom Patent Application No. 1316544.4 dated Nov. 1, 2017. |
| Extended European Search Report dated Apr. 2, 2019 for European Patent Application No. 18215332.0. |
| Extended European Search Report dated Oct. 22, 2019 for European Patent Application No. 19167042.1. |
| Extended European Search Report for European Application No. 17170146 dated Jul. 25, 2017. |
| Extended European Search Report for European Application No. 17170151.9 dated Aug. 22, 2017. |
| Extended European Search Report for European Patent Application No. 12760085.6 dated Sep. 25, 2015. |
| Extended European Search Report for European Patent Application No. 12871735.2 dated Oct. 15, 2015. |
| Extended European Search Report for European Patent Application No. 19166992.8 dated Aug. 2, 2019. |
| Extended European Search Report issued in EP Application 19173274.2 and dated Jul. 29, 2019. |
| International Search Report and Written Opinion dated Sep. 6, 2019 and issued in International Application No. PCT/US2019/019967. |
| International Search Report and Written Opinion for International Application No. PCT/US2012/30350 dated Sep. 13, 2012. |
| International Search Report and Written Opinion for International Application No. PCT/US2012/56781 dated Apr. 4, 2013. |
| Notice of Reasons for Refusal dated Nov. 15, 2018 for Japanese Patent Application No. 2018-071806. |
| Office Action for Chinese Patent Application No. 201280015466.8 dated Apr. 20, 2015 (with translation). |
| Office Action for Japanese Patent Application No. 2014-501276 dated Mar. 1, 2016 (with translation). |
| Office Action for Japanese Patent Application No. 2015-503186 dated Oct. 3, 2017 (with machine translation). |
| Office Action for Japanese Patent Application No. 2015-503186 dated Jun. 6, 2017 (with translation). |
| Office Action for U.S. Appl. No. 14/006,763 dated Dec. 15, 2016. |
| Office Action for U.S. Appl. No. 14/006,763 dated May 16, 2016. |
| Office Action for U.S. Appl. No. 14/006,763 dated Jul. 12, 2017. |
| Office Action for U.S. Appl. No. 14/348,533 dated Feb. 22, 2017. |
| Office Action for U.S. Appl. No. 15/400,978 dated Sep. 21, 2017. |
| Office Action in Japanese Patent Application No. 2015-503186 dated Aug. 2, 2016 (with translation). |
| Partial European Search Report issued in application 19167042.1 and dated Jul. 15, 2019. |
| Partial Supplementary European Search Report for European Patent Application No. 12760085.6 dated Jun. 1, 2015. |
| Agar, “An Obituary For Baxter's Vivia Home HD Machine,” Home Dialysis Central, 2016, pp. 1-11, Home Dialysis Central, Madison, Wisconsin. |
| Agar, “Technology: What's Coming,” Nocturnal Haemodialysis Program, Barwon Health, 2012, pp. 1-8, www.nocturnaldialysis.org/technology_whats_coming.html. |
| Fassbinder, “Experience with the Genius hemodialysis system,” Kidney Blood Press Res., 2003, vol. 26(2), pp. 96-99 (Abstract only), Karger, Basel, Switzerland. |
| Heroux, “Aksys—Dialysis Technologists,” Dialysis Technologists, 2005, pp. 1-5, https://www.tapatalk.com/groups/dialysistechnologists39151/aksys-t607.html. |
| Kjellstrand et al., “The Aksys personal hemodialysis system,” Seminars in Dialysis, 2004, vol. 17(2), Abstract only, Wiley, Hoboken, New Jersey. |
| Office Action (Communication Pursuant to Article 94(3) EPC) dated May 10, 2021, issued in European Application No. 18215332.0. |
| Office Action (Examination Report No. 1) dated Jun. 1, 2021 for Australian Patent Application No. 2019228526. |
| Office Action (Examination Report No. 1) dated Jun. 1, 2021 for Australian Patent Application No. 2020244565. |
| Office Action (Examination Report No. 1) dated Jun. 1, 2021 for Australian Patent Application No. 2020244566. |
| Office Action (Examination Report No. 1) dated Jun. 1, 2021 for Australian Patent Application No. 2020244567. |
| Office Action (Notice of Reasons for Refusal) dated Mar. 1, 2022 for Japanese Patent Application No. 2020-200127. |
| Office Action (Notice of Reasons for Refusal) dated Mar. 22, 2022 for Japanese Patent Application No. 2020-545472. |
| Office Action (Notification of Examination) issued in German Application No. 112012001381.6 dated Mar. 30, 2022. |
| Office Action (Pre-Appeal Examination Report) dated Feb. 9, 2021 for Japanese Patent Application No. 2019-063926. |
| Schlaeper et al., “The Fresenius Medical Care Home Hemodialysis System,” Seminars in Dialysis, 2004, vol. 17 (2), pp. 159-161, Wiley, Hoboken, New Jersey. |
| Unknown, “4008 H—Hemodialysis Machine Operating Instructions,” Fresenius Medical Care AG, Software Version 4.3, May 1, 2005, pp. 1-365. |
| Unknown, “4008 S—Hemodialysis Machine Operating Instructions,” Fresenius Medical Care, Software Version 4.5, Oct. 1, 2011, pp. 1-368. |
| Unknown, “4400HX Hot Water Disinfection Water Treatment Solutions for Hemodialysis,” Mar Car Purification—A Cantel Medical Company, 2006, 4 pages. |
| Unknown, “Aquaboss EcoRO Dia 70—Portable water treatment for hemodialysis,” Lauer Membran Wassertechnik, 2008, Rev. 4.53, Software version 4.00_12, pp. 1-144. |
| Unknown, “AquaUNO Single Station Reverse Osmosis Unit—Operation Instructions,” Fresenius Medical Care, Jul. 1, 2006, Software Version: V2.05, pp. 1-116. |
| Unknown, “Baxter nixes Vivia home hemodialysis machine,” Nephrology News & Issues, 2016, p. 1, Healio, https://www.healio.com/news/nephrology/20180227/baxter-nixes-vivia-home-hemodialysis-machine. |
| Unknown, “Conversion/Retrofit Kit—No. M37525—Connection of an AguaUNO or AquaC UNO H to a 4008” Fresenius Medical Care, 2012, pp. 1-8. |
| Unknown, “User and service manual—Single place reverse osmosis system—RO 4008,” DWA GmbH & Co. KG, Oct. 1, 2008, pp. 1-39. |
| Unknown, “User Interface Design—PHD Personal Hemodialysis System for Aksys,” Brochure, Stream Product Development, Inc., 2020, North Chelmsford, Massachusetts. |
| Unknown, “Xcorporeal, Inc Announces The XCR-6 Dialysis Platform For Self-Directed Kidney Hemodialysis,” Med Device Online, 2008, pp. 1-2, Business Wire, San Francisco, California, https://www.meddeviceonline.com/doc/xcorporeal-inc-announces-the-xcr-6-dialysis-0001. |
| Extended European Search Report dated Feb. 17, 2021 for European Patent Application No. 18821268.2. |
| Office Action dated Mar. 24, 2020 issued in JP Patent App. No. 2019-063926. |
| International Preliminary Report on Patentability dated Sep. 10, 2020, issued in International Application No. PCT/US2019/019967. |
| Office Action dated Aug. 4, 2020, issued in Japanese Application No. 2019-063926. |
| Extended European Search Report dated Oct. 18, 2021, issued in European Application No. 19760761.7. |
| International Search Report and Written Opinion dated Oct. 24, 2018 issued in International Patent Application No. PCT/US2018/039188. |
| Office Action (Communication Pursuant to Article 94(3) EPC) dated Aug. 11, 2022 for European Patent Application No. 19167042.1. |
| Office Action for Japanese Patent Application No. 2014-501276 dated Aug. 9, 2022 (includes English translation). |
| Office Action for Japanese Patent Application No. 2020-200127, dated Apr. 11, 2023. |
| Office Action for Japanese Patent Application No. 2023-063941 issued on Feb. 27, 2024 (includes English language translation). |
| Number | Date | Country | |
|---|---|---|---|
| 20210308349 A1 | Oct 2021 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62524492 | Jun 2017 | US |
